<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7504753</article-id><article-id pub-id-type="doi">10.3390/molecules25173936</article-id><article-id pub-id-type="publisher-id">molecules-25-03936</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Biochemical and Computational Approach of Selected Phytocompounds from <italic>Tinospora crispa</italic> in the Management of COVID-19</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3335-0368</contrib-id><name><surname>Rakib</surname><given-names>Ahmed</given-names></name><xref ref-type="aff" rid="af1-molecules-25-03936">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2767-2646</contrib-id><name><surname>Paul</surname><given-names>Arkajyoti</given-names></name><xref ref-type="aff" rid="af2-molecules-25-03936">2</xref><xref ref-type="aff" rid="af3-molecules-25-03936">3</xref><xref ref-type="aff" rid="af4-molecules-25-03936">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2329-0867</contrib-id><name><surname>Chy</surname><given-names>Md. Nazim Uddin</given-names></name><xref ref-type="aff" rid="af2-molecules-25-03936">2</xref><xref ref-type="aff" rid="af5-molecules-25-03936">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0621-4523</contrib-id><name><surname>Sami</surname><given-names>Saad Ahmed</given-names></name><xref ref-type="aff" rid="af1-molecules-25-03936">1</xref></contrib><contrib contrib-type="author"><name><surname>Baral</surname><given-names>Sumit Kumar</given-names></name><xref ref-type="aff" rid="af4-molecules-25-03936">4</xref></contrib><contrib contrib-type="author"><name><surname>Majumder</surname><given-names>Mohuya</given-names></name><xref ref-type="aff" rid="af2-molecules-25-03936">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2704-7610</contrib-id><name><surname>Tareq</surname><given-names>Abu Montakim</given-names></name><xref ref-type="aff" rid="af5-molecules-25-03936">5</xref></contrib><contrib contrib-type="author"><name><surname>Amin</surname><given-names>Mohammad Nurul</given-names></name><xref ref-type="aff" rid="af6-molecules-25-03936">6</xref></contrib><contrib contrib-type="author"><name><surname>Shahriar</surname><given-names>Asif</given-names></name><xref ref-type="aff" rid="af7-molecules-25-03936">7</xref></contrib><contrib contrib-type="author"><name><surname>Uddin</surname><given-names>Md. Zia</given-names></name><xref ref-type="aff" rid="af3-molecules-25-03936">3</xref><xref ref-type="aff" rid="af8-molecules-25-03936">8</xref></contrib><contrib contrib-type="author"><name><surname>Dutta</surname><given-names>Mycal</given-names></name><xref ref-type="aff" rid="af3-molecules-25-03936">3</xref><xref ref-type="aff" rid="af8-molecules-25-03936">8</xref></contrib><contrib contrib-type="author"><name><surname>Tallei</surname><given-names>Trina Ekawati</given-names></name><xref ref-type="aff" rid="af9-molecules-25-03936">9</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3188-2272</contrib-id><name><surname>Emran</surname><given-names>Talha Bin</given-names></name><xref ref-type="aff" rid="af3-molecules-25-03936">3</xref><xref rid="c1-molecules-25-03936" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9215-9737</contrib-id><name><surname>Simal-Gandara</surname><given-names>Jesus</given-names></name><xref ref-type="aff" rid="af10-molecules-25-03936">10</xref><xref rid="c1-molecules-25-03936" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>McPhee</surname><given-names>Derek J.</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-25-03936"><label>1</label>Department of Pharmacy, Faculty of Biological Sciences, University of Chittagong, Chittagong 4331, Bangladesh; <email>rakib.pharmacy.cu@gmail.com</email> (A.R.); <email>s.a.sami18pharm@gmail.com</email> (S.A.S.)</aff><aff id="af2-molecules-25-03936"><label>2</label>Drug Discovery, GUSTO A Research Group, Chittagong 4000, Bangladesh; <email>arka.bgctub@gmail.com</email> (A.P.); <email>nazim107282@gmail.com</email> (M.N.U.C.); <email>mohuyamajumderbgctub@gmail.com</email> (M.M.)</aff><aff id="af3-molecules-25-03936"><label>3</label>Department of Pharmacy, BGC Trust University Bangladesh, Chittagong 4381, Bangladesh; <email>zia@bgctub.ac.bd</email> (M.Z.U.); <email>mycal@bgctub.ac.bd</email> (M.D.)</aff><aff id="af4-molecules-25-03936"><label>4</label>Department of Microbiology, Jagannath University, Dhaka 1100, Bangladesh; <email>akbaiub6@gmail.com</email></aff><aff id="af5-molecules-25-03936"><label>5</label>Department of Pharmacy, International Islamic University Chittagong, Chittagong 4318, Bangladesh; <email>montakim0.abu@gmail.com</email></aff><aff id="af6-molecules-25-03936"><label>6</label>Department of Pharmacy, Atish Dipankar University of Science and Technology, Dhaka 1230, Bangladesh; <email>amin.pharma07@gmail.com</email></aff><aff id="af7-molecules-25-03936"><label>7</label>Department of Microbiology, Stamford University Bangladesh, 51 Siddeswari Road, Dhaka 1217, Bangladesh; <email>abasifbl@gmail.com</email></aff><aff id="af8-molecules-25-03936"><label>8</label>Department of Pharmacy, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh</aff><aff id="af9-molecules-25-03936"><label>9</label>Department of Biology, Faculty of Mathematics and Natural Sciences, Sam Ratulangi University, Manado 95115, Indonesia; <email>trina_tallei@unsrat.ac.id</email></aff><aff id="af10-molecules-25-03936"><label>10</label>Nutrition and Bromatology Group, Department of Analytical and Food Chemistry, Faculty of Food Science and Technology, University of Vigo&#x02013;Ourense Campus, E32004 Ourense, Spain</aff><author-notes><corresp id="c1-molecules-25-03936"><label>*</label>Correspondence: <email>talhabmb@bgctub.ac.bd</email> (T.B.E.); <email>jsimal@uvigo.es</email> (J.S.-G.); Tel.: +88-01819-942214 (T.B.E.); +34-988-387000 (J.S.-G.)</corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>8</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2020</year></pub-date><volume>25</volume><issue>17</issue><elocation-id>3936</elocation-id><history><date date-type="received"><day>10</day><month>8</month><year>2020</year></date><date date-type="accepted"><day>27</day><month>8</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>A pandemic caused by the novel coronavirus (SARS-CoV-2 or COVID-19) began in December 2019 in Wuhan, China, and the number of newly reported cases continues to increase. More than 19.7 million cases have been reported globally and about 728,000 have died as of this writing (10 August 2020). Recently, it has been confirmed that the SARS-CoV-2 main protease (M<sup>pro)</sup> enzyme is responsible not only for viral reproduction but also impedes host immune responses. The M<sup>pro</sup> provides a highly favorable pharmacological target for the discovery and design of inhibitors. Currently, no specific therapies are available, and investigations into the treatment of COVID-19 are lacking. Therefore, herein, we analyzed the bioactive phytocompounds isolated by gas chromatography&#x02013;mass spectroscopy (GC-MS) from <italic>Tinospora crispa</italic> as potential COVID-19 M<sup>pro</sup> inhibitors, using molecular docking study. Our analyses unveiled that the top nine hits might serve as potential anti-SARS-CoV-2 lead molecules, with three of them exerting biological activity and warranting further optimization and drug development to combat COVID-19.</p></abstract><kwd-group><kwd>SARS-CoV-2</kwd><kwd>COVID-19</kwd><kwd><italic>Tinospora crispa</italic></kwd><kwd>natural products</kwd><kwd>phytochemicals</kwd><kwd>secondary metabolites</kwd><kwd>molecular docking</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-25-03936"><title>1. Introduction</title><p>In late December 2019, Severe Acute Respiratory Disorder Coronavirus 2 (SARS-CoV-2) became an outbreak in China and then spread to other countries. Infected persons exhibit pneumonia indications, progressing to severe acute respiratory disorder. In January 2020, it was confirmed that an unknown sort of coronavirus named SARS-CoV-2 (formerly named as 2019-nCoV) had come out. On February 11, 2020, the World Health Organization (WHO) named the Wuhan pneumonia as Coronavirus Disease-2019 (COVID-19) and declared this infectious disease to be a global pandemic. Certain animals, including mammals, reptiles, and birds prone to this infectious disease caused by the virus are deadly, while there have been several deaths by respiratory contamination transmitted from animal to human then transmitted to humans [<xref rid="B1-molecules-25-03936" ref-type="bibr">1</xref>,<xref rid="B2-molecules-25-03936" ref-type="bibr">2</xref>].</p><p>The virus, known as coronavirus, a single RNA-stranded virus, belongs to the <italic>Coronaviridae</italic> family. The RNA is encapsulated in the membrane, and the virion contains phosphorylated nucleocapsid protein and RNA. By interacting with the angiotensin-converting-enzyme-2 (ACE2) receptor, the virus enters the host and causes severe respiratory tract infection (RTI) in humans. Viral proteases have been well documented as potential approved drug targets for several infections, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV) [<xref rid="B3-molecules-25-03936" ref-type="bibr">3</xref>]. Recent studies from Liu and his group documented the presence of the main protease (M<sup>pro</sup>) enzyme in SARS-CoV-2 [<xref rid="B4-molecules-25-03936" ref-type="bibr">4</xref>]. Homology modeling with SARS-CoV M<sup>pro</sup> has delineated about a 96% structural similarity with SARS-CoV M<sup>pro</sup> [<xref rid="B5-molecules-25-03936" ref-type="bibr">5</xref>]. Due to the structural similarity with the M<sup>pro</sup> from other coronaviruses, SARS-CoV-2 M<sup>pro</sup> can be considered to be a prospective target for drug discovery for COVID-19 treatment. SARS-CoV-2 M<sup>pro</sup> cleaves the overlapping pp1a and pp1b polyproteins through proteolytic cleavage, which is considered to be a critical step for viral replication [<xref rid="B6-molecules-25-03936" ref-type="bibr">6</xref>,<xref rid="B7-molecules-25-03936" ref-type="bibr">7</xref>,<xref rid="B8-molecules-25-03936" ref-type="bibr">8</xref>]. Additionally, the functioning of replication-essential enzymes, for instance, RNA-dependent RNA polymerase (RdRp), nsp13 are also dependent on the proteolytic release [<xref rid="B9-molecules-25-03936" ref-type="bibr">9</xref>]. Consequently, SARS-CoV-2 M<sup>pro</sup> is responsible for inhibiting SARS-CoV-2 replication. Therefore, targeting this specific enzyme will lead towards potential therapeutic advantages in drug discovery for this dangerous virus.</p><p>Scientists from all over the world are coming together and working simultaneously to fight against this deadly disease. However, so far, specific therapies regarding the treatment have been too little, and measures that have been implied are restricted to limited supportive and preventive therapies. Experimental trials have been carried out using a combination of lopinavir/ritonavir, which are commonly used to treat human immunodeficiency virus (HIV) infection [<xref rid="B10-molecules-25-03936" ref-type="bibr">10</xref>]. Another experiment using four FDA approved drugs, including nelfinavir, pitavastatin, perampanel, and praziquantel, identified nelfinavir as a potent inhibitor for SARS-CoV-2 M<sup>pro</sup> enzyme [<xref rid="B11-molecules-25-03936" ref-type="bibr">11</xref>]. Although trials have already been carried out for the treatment of SARS-CoV-2 infection, preliminary investigations remain unapproved regarding their use.</p><p>Researchers have recently been searching for potent therapeutic agents from medicinal plants for SARS-CoV-2 infection [<xref rid="B12-molecules-25-03936" ref-type="bibr">12</xref>]. Different secondary metabolites, including alkaloids, flavonoids, tannins, glycosides, lignin, and terpenes, are available from medicinal plants. Various studies have already established the function of phytochemicals in treating various infections and diseases [<xref rid="B13-molecules-25-03936" ref-type="bibr">13</xref>,<xref rid="B14-molecules-25-03936" ref-type="bibr">14</xref>,<xref rid="B15-molecules-25-03936" ref-type="bibr">15</xref>,<xref rid="B16-molecules-25-03936" ref-type="bibr">16</xref>,<xref rid="B17-molecules-25-03936" ref-type="bibr">17</xref>,<xref rid="B18-molecules-25-03936" ref-type="bibr">18</xref>]. Moreover, compound isolation and further investigation of several pharmacological activities have been established as a crucial factor in drug discovery [<xref rid="B19-molecules-25-03936" ref-type="bibr">19</xref>].</p><p>In the present study, we tried to identify the role of some isolated phytochemicals from a medicinal plant, known as <italic>Tinospora crispa</italic> Miers., a member of the Menispermaceae family, for the treatment of COVID-19 using computational biology techniques. The plant is locally known as Gulancha [<xref rid="B20-molecules-25-03936" ref-type="bibr">20</xref>]. It is indigenous to Bangladesh, Eastern China, India, and Malaysia. Our previous work also confirmed the hepatoprotective, antinociceptive, anxiolytic, antidepressant, and antipyretic activities of plant extract and fractions of <italic>T. crispa</italic> [<xref rid="B21-molecules-25-03936" ref-type="bibr">21</xref>,<xref rid="B22-molecules-25-03936" ref-type="bibr">22</xref>]. Moreover, the ethnobotanical role of the plant has already been documented, primarily as a tonic, a blood purifier, and for stomach disorders [<xref rid="B20-molecules-25-03936" ref-type="bibr">20</xref>]. Importantly, the plant exhibited significant antimalarial attributes in combination with pyrimethamine, which corroborates the findings from recent studies providing evidence for the use of the antimalarial drug chloroquine and hydroxychloroquine to combat against SARS-CoV-2 [<xref rid="B23-molecules-25-03936" ref-type="bibr">23</xref>,<xref rid="B24-molecules-25-03936" ref-type="bibr">24</xref>,<xref rid="B25-molecules-25-03936" ref-type="bibr">25</xref>]. In addition, one study reported the antiviral activity of <italic>T. crispa</italic> along with other traditional herbs delineated antiviral activity against fish pathogenic viruses, including infectious hematopoietic necrosis virus, infectious pancreatic necrosis virus, <italic>Oncorhynchus masou</italic> virus [<xref rid="B26-molecules-25-03936" ref-type="bibr">26</xref>]. The active components from another species of <italic>Tinospora</italic> (<italic>T. cordifolia</italic>) has been shown to represent not only antiviral activity but also protease inhibitor activity [<xref rid="B27-molecules-25-03936" ref-type="bibr">27</xref>]. Therefore, this study rationalizes the role of screened compounds of <italic>T. crispa</italic> to combat SARS-CoV-2.</p></sec><sec sec-type="results" id="sec2-molecules-25-03936"><title>2. Results</title><sec id="sec2dot1-molecules-25-03936"><title>2.1. GC-MS Analysis</title><p>In 50 min retention time, the methanol extract of <italic>T. crispa</italic> contained a total of 309 compounds eluted between 5.0&#x02013;40.0 min (<xref ref-type="fig" rid="molecules-25-03936-f001">Figure 1</xref>). Fifty-six (56) bioactive compounds were selected for this study (<xref rid="molecules-25-03936-t001" ref-type="table">Table 1</xref>).</p></sec><sec id="sec2dot2-molecules-25-03936"><title>2.2. Prediction of Active Site</title><p>Using the CASTp server, we sought to identify the active pockets of the PDB protein. The area was depicted as 304.266, and the volume was 296.682. A total of 27 active site residues were identified by CASTp server, and the residues were Thr25, Thr26, Leu27, His41, Cys44, Thr45, Ser46, Met49, Pro52, Tyr54, Phe140, Leu141, Asn142, Gly143, Ser144, His163, His164, Met165, Glu166, Leu167, Pro168, His172, Asp187, Arg188, Gln189, Thr190, and Gln192.</p></sec><sec id="sec2dot3-molecules-25-03936"><title>2.3. Ligand-Based ADME/T Prediction</title><p>Lipinski&#x02019;s rule of five was followed to predict the drug-likeliness properties; the following five principles must be followed: (i) Molecular weight is not more than 500; (ii) Number of H-bond acceptors &#x02264; 10; (iii) Number of H-bond donors &#x02264; 5; (iv) Lipophilicity (Log <italic>P</italic> value) &#x0003c; 5; and (v) Molar refractivity between 40 to 130. Among the fifty-six compounds, twenty-three compounds fulfilled the rule of five, indicating that those compounds could be suitable for the new drug development process. The results of the ADME/T prediction of the compounds is exhibited in <xref rid="molecules-25-03936-t002" ref-type="table">Table 2</xref>.</p></sec><sec id="sec2dot4-molecules-25-03936"><title>2.4. Molecular Docking</title><p>In this study, we are able to delineate the interaction between several isolated compounds of <italic>T. crispa</italic> with the M<sup>pro</sup> enzyme of SARS-CoV-2 (PDB ID: 6W63). The docking results demonstrated that all compounds obtained from <italic>T. crispa</italic> interacted with the SARS-CoV-2 M<sup>pro</sup> enzyme. Among these compounds, a total of seven possess higher docking scores in comparison with the others (<xref ref-type="fig" rid="molecules-25-03936-f002">Figure 2</xref>). However, some compounds exert a lower binding affinity towards the receptor (<xref rid="molecules-25-03936-t003" ref-type="table">Table 3</xref>). </p><p>Our computational investigation shows that imidazolidin-4-one, 2-imino-1-(4-methoxy-6-dimethylamino-1,3,5-triazin-2-yl) has the lowest docking score of &#x02212;7.013 KJ/mol, interacting with Gly143 and Ser144 residues, respectively (<xref ref-type="fig" rid="molecules-25-03936-f003">Figure 3</xref>).</p><p>Additionally, spiro[4,5]dec-6-en-1-ol, 2,6,10,10-tetramethyl exhibits a docking score of &#x02212;6.369 KJ/mol, but the interaction occurs with total four amino acids (Met165, His41, Met49, Met165) through pi-alkyl stacking, unlike imidazolidin-4-one, 2-imino-1-(4-methoxy-6-dimethylamino-1,3,5-triazin-2-yl), which interacts through hydrogen bonding (<xref ref-type="fig" rid="molecules-25-03936-f004">Figure 4</xref>). Moreover, 3.beta-Hydroxy-5-cholen-24-oic acid also tends to interact with the receptor as it has obtained a docking score of &#x02212;6.251 KJ/mol. In addition, 3.beta-Hydroxy-5-cholen-24-oic acid possessed the affinity towards the receptor not only through hydrogen bonding but also pi-alkyl stacking (<xref ref-type="fig" rid="molecules-25-03936-f005">Figure 5</xref>). On the other hand, dibutyl phthalate (&#x02212;2.279 kcal/mol) possessed the lowest score (<xref rid="molecules-25-03936-t003" ref-type="table">Table 3</xref>). In particular, our experiment also includes the calculation of binding affinity of two antiviral agents, nelfinavir and lopinavir and these aforementioned compounds exert a score of &#x02212;7.596 and &#x02212;8.251 Kcal/mol, respectively, withSARS-CoV-2 M<sup>pro</sup>. The molecular docking analysis results are shown in <xref ref-type="fig" rid="molecules-25-03936-f003">Figure 3</xref>, <xref ref-type="fig" rid="molecules-25-03936-f004">Figure 4</xref> and <xref ref-type="fig" rid="molecules-25-03936-f005">Figure 5</xref>, <xref ref-type="app" rid="app1-molecules-25-03936">Figures S1&#x02013;S13</xref>, and <xref rid="molecules-25-03936-t003" ref-type="table">Table 3</xref>.</p></sec><sec id="sec2dot5-molecules-25-03936"><title>2.5. Prediction of Biological Activity</title><p>The selected compounds of the plant <italic>T. crispa</italic> were subjected to biological activity calculations with the help of Molinspiration software and compared with the standard drugs nelfinavir and lopinavir. The results are shown in <xref rid="molecules-25-03936-t004" ref-type="table">Table 4</xref>.</p></sec></sec><sec sec-type="discussion" id="sec3-molecules-25-03936"><title>3. Discussion</title><p>Currently, with an acute progression rate, it has been revealed that the clinical manifestations of SARS-CoV-2 infection start with a fever with a dry cough, which continues to alveolar edema, ultimately resulting in difficulty in breathing; however, mild symptoms might not include high fever [<xref rid="B28-molecules-25-03936" ref-type="bibr">28</xref>,<xref rid="B29-molecules-25-03936" ref-type="bibr">29</xref>,<xref rid="B30-molecules-25-03936" ref-type="bibr">30</xref>]. Nevertheless, as the death counts are rising alarmingly, the respiratory infection triggered by SARS-CoV-2 has been classified as more critical in progressing the disease state in contrast with two other coronaviruses, SARS and MERS (Middle East Respiratory Syndrome), with a large number of infections and variations that spread rapidly while exhibiting minimal symptoms in the lungs. The organism can depreciate the normal functioning of the kidney, heart, liver, and other vital organs, leading to systemic exhaustion [<xref rid="B31-molecules-25-03936" ref-type="bibr">31</xref>,<xref rid="B32-molecules-25-03936" ref-type="bibr">32</xref>,<xref rid="B33-molecules-25-03936" ref-type="bibr">33</xref>].</p><p>Although several kinds of research are being carried out in famous laboratories in several countries, vaccine development for disease is usually time-consuming. Despite there being plenty of experimental trials associated with COVID-19 treatment and medications, as of yet, scientists are still on the hunt for specific therapeutic drugs [<xref rid="B34-molecules-25-03936" ref-type="bibr">34</xref>].</p><p>About 80% of certain Asian and African countries depend on traditional medicine for their major health care needs [<xref rid="B35-molecules-25-03936" ref-type="bibr">35</xref>]. Several endogenous receptors responsible for prominent biological functions are triggered by numerous plant-derived phytochemicals [<xref rid="B36-molecules-25-03936" ref-type="bibr">36</xref>]. Medicinal plants are endowed with plenty of phytocompounds, and since ancient times, plant-derived compounds have been used for treatment in numerous diseases [<xref rid="B15-molecules-25-03936" ref-type="bibr">15</xref>,<xref rid="B37-molecules-25-03936" ref-type="bibr">37</xref>,<xref rid="B38-molecules-25-03936" ref-type="bibr">38</xref>]. Diverse secondary metabolites, including alkaloids, terpenoids, lignans, glycosides, amino acids, are crucial for the growth and functioning of plants and have numerous pharmacological aspects of fighting against several abnormal conditions [<xref rid="B39-molecules-25-03936" ref-type="bibr">39</xref>,<xref rid="B40-molecules-25-03936" ref-type="bibr">40</xref>,<xref rid="B41-molecules-25-03936" ref-type="bibr">41</xref>]. Archaically, plant-derived chemicals were considered to be a prolific fount for drug discovery. Several previous studies have already documented the essentiality of phytochemicals in numerous diseases, including cardiovascular diseases, cancer, diabetes, hepatic disorders, etc. [<xref rid="B42-molecules-25-03936" ref-type="bibr">42</xref>,<xref rid="B43-molecules-25-03936" ref-type="bibr">43</xref>,<xref rid="B44-molecules-25-03936" ref-type="bibr">44</xref>]. Many of these phytochemicals are generally not involved in the normal functioning of plants; nonetheless, they are modified by various biochemical processes and are further required for various environmental responses, including stress, protection from ultraviolet damage [<xref rid="B45-molecules-25-03936" ref-type="bibr">45</xref>]. The extraction of phytochemicals has recently been established as a phenomenal subject matter in lead compound identification for active pharmaceutical moieties. More detailed information about various pharmacologically active medicinal plants&#x02019; crude extracts could be obtained using separation techniques, which involves the separation of active phytoconstituents [<xref rid="B46-molecules-25-03936" ref-type="bibr">46</xref>,<xref rid="B47-molecules-25-03936" ref-type="bibr">47</xref>]. In this experiment, we used the GC-MS technique for qualitative analysis of the plant extracts of <italic>T. crispa</italic> and confirmed more than 300 compounds.</p><p>Recently, researchers from different parts of the world have been working extensively to find certain potential lead compounds from medicinal plants that are active against several enzymes and other proteins responsible for viral replication and growth [<xref rid="B33-molecules-25-03936" ref-type="bibr">33</xref>,<xref rid="B48-molecules-25-03936" ref-type="bibr">48</xref>,<xref rid="B49-molecules-25-03936" ref-type="bibr">49</xref>]. In line with this, we planned in silico experiments using the isolated constituents from methanol extract of <italic>T. crispa</italic> against the SARS-CoV-2 M<sup>pro</sup> enzyme. Significantly, we have already mentioned the role of <italic>T. crispa</italic> extracts against malaria and the recent successful usage of anti-malarial drugs in combatting COVID-19, which leads the foundation for our hypothesis.</p><p>Nowadays, drug design using various bioinformatics tools has been proven as groundbreaking methods in drug discovery not only due to promptness and accuracy but also its low cost [<xref rid="B50-molecules-25-03936" ref-type="bibr">50</xref>]. Molecular docking simulation, a form of bioinformatics analysis, signifies the binding affinities of ligand molecules with a specific receptor, in which the lower binding energy predicts the higher binding affinity [<xref rid="B51-molecules-25-03936" ref-type="bibr">51</xref>,<xref rid="B52-molecules-25-03936" ref-type="bibr">52</xref>,<xref rid="B53-molecules-25-03936" ref-type="bibr">53</xref>]. A recent study from Yamamoto et al. has already shown that nelfinavir can inhibit SARS-CoV-2 replication in vitro [<xref rid="B54-molecules-25-03936" ref-type="bibr">54</xref>]. Previously, another study from Yamamoto et al. reported the inhibitory effect of nelfinavir on the replication of SARS-CoV [<xref rid="B55-molecules-25-03936" ref-type="bibr">55</xref>]. In addition, another in vitro analysis showed that lopinavir/ritonavir exhibited potential inhibitory effects on SARS-CoV-2 [<xref rid="B56-molecules-25-03936" ref-type="bibr">56</xref>]. Hence, we selected nelfinavir and lopinavir as positive controls in the present study. In this study, our selected phytocompounds, along with two antiviral drugs, nelfinavir and lopinavir, were able to dock with the active pockets of SARS-CoV-2 M<sup>pro</sup> enzyme, which was confirmed by our analysis through CASTp web server. Despite showing lower binding affinities than nelfinavir and lopinavir, our selected compounds interacted with the active pockets of the SARS-CoV-2 M<sup>pro</sup> enzyme like the standard compounds. Additionally, imidazolidin-4-one, 2-imino-1-(4-methoxy-6-dimethylamino-1,3,5-triazin-2-yl) not only has a docking score almost the same as nelfinavir, but also, like nelfinavir, interacts with Glu166 residue through H-bonding. On the other hand, the interactions between spiro[4,5]dec-6-en-1-ol, 2,6,10,10-tetramethyl and 3.beta-hydroxy-5-cholen-24-oic acid with SARS-CoV-2 M<sup>pro</sup> enzyme were found to be more than both the standard drugs. Additionally, other compounds, including androstan-17-one, 3-ethyl-3-hydroxy-, (5.alpha), camphenol, (&#x02212;)-Globulol, yangambin, nordazepam, TMS derivative, and benzeneethanamine, also represented greater interaction with the abovementioned enzyme. Previously, it was found that the His41 and Cys145 residues belong to the catalytic dyads of the SARS-CoV-2 M<sup>pro</sup> [<xref rid="B57-molecules-25-03936" ref-type="bibr">57</xref>]. In the current study, the results of the docking analysis revealed that retinal, retinol, spiro[4,5]dec-6-en-1-ol, 2,6,10,10-tetramethyl, phosphonoacetic Acid, 3TMS derivative, aR-turmerone, androstan-17-one, 3-ethyl-3-hydroxy-, (5.alpha) interacted with Cys145 residue through hydrophobic interaction. Furthermore, the two standard drugs, along with most of the selected compounds, interacted with His41 residue. Like nelfinavir, benzeneethanamine also yielded interaction with His41 residue by forming hydrogen bonds. Although neither nelfinavir nor lopinavir interacted with Met49 residues, most of the targeted compounds interacted with Met49 residues, and this residue, along with His41, is crucial for substrate-binding [<xref rid="B57-molecules-25-03936" ref-type="bibr">57</xref>]. In addition, Gly143, Ser144, His163, His164, Met165, Glu166, Leu167, Asp187, Arg188, Gln189, Thr190, Ala191, and Gln192 residues are also crucial for substrate binding in SARS-CoV-2 M<sup>pro</sup> [<xref rid="B58-molecules-25-03936" ref-type="bibr">58</xref>,<xref rid="B59-molecules-25-03936" ref-type="bibr">59</xref>]. Our analysis showed that 3,4-dihydroxymandelic interacted with His163, Ser144 from the substrate-binding domain through hydrogen bonding. In addition, camphenol, possessing a greater docking score, formed a hydrogen bond with substrate-binding His164 residue. Moreover, most of the selected compounds as well as nelfinavir interacted with Met165 residue by forming a hydrophobic interaction.</p><p>Moreover, the selected compounds also followed Lipinski&#x02019;s rule of five for drug-likeness properties. Furthermore, the ion channel inhibitor property of spiro[4,5]dec-6-en-1-ol, 2,6,10,10-tetramethyl were found more than standard compounds. Additionally, imidazolidin-4-one, 2-imino-1-(4-methoxy-6-dimethylamino-1,3,5-triazin-2-yl) possessed closer kinase inhibitor attributes in comparison with the standards. In addition, 3.beta-Hydroxy-5-cholen-24-oic acid exerted greater nuclear receptor ligand than nelfinavir and lopinavir. Interestingly, both spiro[4,5]dec-6-en-1-ol, 2,6,10,10-tetramethyl, 3.beta-Hydroxy-5-cholen-24-oic acid and 3.beta-Hydroxy-5-cholen-24-oic acid presented greater enzyme inhibition than either antiviral drug, whereas imidazolidin-4-one, 2-imino-1-(4-methoxy-6-dimethylamino-1,3,5-triazin-2-yl) exhibited greater protease blocking activity.</p></sec><sec id="sec4-molecules-25-03936"><title>4. Materials and Methods</title><sec id="sec4dot1-molecules-25-03936"><title>4.1. Plant Collection</title><p>The whole plant of <italic>T. crispa</italic> was collected at the mature stage from the Lawachara National Park, Moulavi Bazar, Bangladesh, in January 2018. The plant parts were cut into small pieces that were washed under tap water and then dried in the dark at 21&#x02013;30 &#x000b0;C for 15 days. The whole plant material was ground by a mechanical grinder and passed through a size of 60 mesh sieve to obtain a fine powder that was stored in an air-tight container.</p></sec><sec id="sec4dot2-molecules-25-03936"><title>4.2. Preparation of Extracts</title><p>The dried <italic>T. crispa</italic> plant powder (600 g) was macerated in 4 L methanol (Merck, Darmstadt, Germany) for 15 days at room temperature with occasional shaking and stirring. Following filtration, first with a cotton plug, then with a Whatman No. 1 filter paper, the filtrate was evaporated to dryness under vacuum at 40 &#x000b0;C to obtain a concentrated extract (30.55 g dry weight, 5.09% <italic>w</italic>/<italic>w</italic>). The extract was preserved for further analysis.</p></sec><sec id="sec4dot3-molecules-25-03936"><title>4.3. Gas Chromatography&#x02013;Mass Spectroscopy (GC-MS) Analysis</title><p>The GC-MS analysis was evaluated using a model 7890A capillary gas chromatography along with a mass spectrometer (Agilent Technologies, Santa Clara, CA, USA). The column was a fused silica capillary column of 95% dimethyl-poly siloxane and 5% phenyl (HP-5MSI; length: 90 m, diameter: 0.250 mm and film: 0.25 &#x000b5;m, Merck, Darmstadt, Germany). Parameters for GC-MS detection were an injector temperature of 250 &#x000b0;C, and the initial oven temperature of 90 &#x000b0;C was gradually raised to 200 &#x000b0;C at a speed of 3 &#x000b0;C/min for 2 min and with a final increase to 280 &#x000b0;C at 15 &#x000b0;C/min for 2 min. The total GC-MS run time was 36 min, using 99.999% helium as a carrier gas, at a column flow rate of 1 mL/min. The GC to MS interface temperature was fixed at 280 &#x000b0;C, and an electron ionization system was set on the MS in scan mode. The mass range evaluated was 50&#x02013;550 <italic>m</italic>/<italic>z</italic>, where MS quad and source temperatures were maintained at 150 &#x000b0;C and 230 &#x000b0;C, respectively. The NIST-MS Library 2009 was used to search and identify each component, and to measure the relative percentage of each compound, relative peak areas of the TIC (total ionic chromatogram) were used, with calculations performed automatically.</p></sec><sec id="sec4dot4-molecules-25-03936"><title>4.4. Active Site Prediction</title><p>Potential ligand binding sites/pockets (active sites) on the 3D structure of protein were identified by the CASTp web server (<uri xlink:href="http://sts.bioe.uic.edu/castp/">http://sts.bioe.uic.edu/castp/</uri>) [<xref rid="B60-molecules-25-03936" ref-type="bibr">60</xref>]. CASTp uses the recent algorithmic and geometrical analysis of computational chemistry for the analytical validation pockets and cavities.</p></sec><sec id="sec4dot5-molecules-25-03936"><title>4.5. In Silico ADME Analysis</title><p>The pharmacokinetic properties of all major identified compounds were evaluated using Lipinski&#x02019;s rule of five [<xref rid="B61-molecules-25-03936" ref-type="bibr">61</xref>]. Lipinski stated that a compound could show drug-like behavior if it does not fail more than one of the following criteria: (i) Molecular weight is not more than 500; (ii) H-bond donors &#x02264; 5; (iii) H-bond acceptors &#x02264; 10; (iv) Lipophilicity &#x0003c; 5; and (v) Molar refractivity between 40 and 130. The web tool Swiss ADME was used to assess the ADME parameters of all compounds. Compounds obeying the Lipinski rule are considered as ideal drug candidates [<xref rid="B62-molecules-25-03936" ref-type="bibr">62</xref>].</p></sec><sec id="sec4dot6-molecules-25-03936"><title>4.6. Computational Molecular Docking Analysis</title><sec id="sec4dot6dot1-molecules-25-03936"><title>4.6.1. Ligand Preparation</title><p>The selected isolated compounds of <italic>T. crispa</italic> were subjected to Maestro v 10.1 (Schr&#x000f6;dinger suite, LLC New York, NY, USA), and ligand preparation was done using the LigPrep tool. The parameters were set to neutralize at pH 7.0 &#x000b1; 2.0 using Epik 2.2, and minimized by force field OPLS_2005.</p></sec><sec id="sec4dot6dot2-molecules-25-03936"><title>4.6.2. Protein Preparation</title><p>3D crystal structure of SARS-CoV-2 M<sup>pro</sup> (PDB ID: 6W63) was downloaded from the Protein Data Bank and prepared using the protein preparation wizard of the Schr&#x000f6;dinger Suite&#x02014;Maestro version 10.1. Charges and bond orders were assigned, hydrogens added to heavy atoms and selenomethionines and selenocysteines converted into methionines and cysteines, respectively, followed by removing all water molecules. Using force field OPLS_2005, minimization was performed to set a maximum heavy atom RMSD to 0.30 &#x000c5;.</p></sec><sec id="sec4dot6dot3-molecules-25-03936"><title>4.6.3. Receptor Grid Generation and Molecular Docking</title><p>Receptor grid generation and molecular docking experiments were performed using Glide (Schr&#x000f6;dinger Suite&#x02014;Maestro version 10.1) [<xref rid="B63-molecules-25-03936" ref-type="bibr">63</xref>,<xref rid="B64-molecules-25-03936" ref-type="bibr">64</xref>]. A grid was produced for each protein using the following default parameters: van der Waals scaling factor 1.00 and charge cut-off value 0.25, subjected to the OPLS_2005 force field. A cubic box of definite dimensions centered on the centroid of the active site residues was generated for the receptor, and the box size was set to 14 &#x000c5; &#x000d7; 14 &#x000c5; &#x000d7; 14 &#x000c5; for docking. Docking experiments were carried out using the standard precision (SP) scoring function of glide, and only the best scoring fit with docking score was noted for each ligand.</p></sec></sec><sec id="sec4dot7-molecules-25-03936"><title>4.7. Biological Activity Prediction</title><p>The targeted compounds were assessed for potential bioactivity by calculating their activity scores as GPCR ligands, ion channel modulators, kinase inhibitors, nuclear receptor inhibitors, and enzyme inhibitors. All the parameters were checked with the aid of the software Molinspiration (<uri xlink:href="www.molinspiration.com">www.molinspiration.com</uri>, Nova Ulica, Slovensky Grob, Slovak Republic) [<xref rid="B21-molecules-25-03936" ref-type="bibr">21</xref>]. Calculated drug-likeness scores of each compound were compared with each compound&#x02019;s specific activity and were compared with the standard drugs (nelfinavir and lopinavir).</p></sec></sec><sec sec-type="conclusions" id="sec5-molecules-25-03936"><title>5. Conclusions</title><p>COVID-19 created a devastating global crisis impacting thousands of people every day, taking thousands of lives and hampering the global economy. Virtual molecular docking was conducted to identify new compounds that could bind the SARS-CoV-2 M<sup>pro</sup>. The isolated compounds obtained from the methanol extract of <italic>T. crispa</italic> were investigated in silico, which concluded that some selective compounds are potentially enough to alter the activity of the SARS-CoV-2 M<sup>pro</sup> enzyme. Our analysis indicates phytochemicals from the methanolic extract of <italic>T. crispa</italic> such as imidazolidin-4-ne, 2-imino-1-(4-methoxy-6-dimethylamino-1,3,5-triazin-2-yl), spiro[4,5]dec-6-en-1-ol, 2,6,10,10-tetramethyl, 3.beta-hydroxy-5-cholen-24-oic acid, androstan-17-one, 3-ethyl-3-hydroxy-(5.alpha), camphenol, (&#x02212;)-Globulol, yangambin, nordazepam, TMS derivative, benzeneethanamine have a better binding affinity to M<sup>pro</sup> of SARS-CoV-2 compared to nelfinavir and lopinavir. Further research and development will pave the way for identifying possible SARS-CoV-2 M<sup>pro</sup> inhibitors. We anticipate that the insights obtained in this study can be useful for the potential discovery and development of new natural anti-COVID-19 therapeutic agents.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to thank Cambridge Proofreading &#x00026; Editing LLC. (<uri xlink:href="https://proofreading.org/">https://proofreading.org/</uri>) for editing a draft of this manuscript.</p></ack><fn-group><fn><p><bold>Sample Availability:</bold> Samples of the compounds are available from the authors.</p></fn></fn-group><app-group><app id="app1-molecules-25-03936"><title>Supplementary Materials</title><p>The following are available online. Figure S1: 2D and 3D interactions of Benzeneethanamine (A) and Camphenol (B) with the active site of SARS-CoV-2 M<sup>pro</sup> (PDB ID: 6W63); Figure S2: 2D and 3D interactions of Strophanthidin (C) and Retinal (D) with the active site of SARS-CoV-2 M<sup>pro</sup> (PDB ID: 6W63); Figure S3: 2D and 3D interactions of Trans-geranylgeraniol (E) and 3,4-Dihydroxymandelic acid (F) with the active site of SARS-CoV-2 M<sup>pro</sup> (PDB ID: 6W63); Figure S4. 2D and 3D interactions of Imidazolidin-4-one, 2-imino-1-(4-methoxy-6-dimethylamino-1,3,5-triazin-2-yl) (G) and Retinol (F) with the active site of SARS-CoV-2 M<sup>pro</sup> (PDB ID: 6W63); Figure S5: 2D and 3D interactions of alpha-Santalol (I) and Santalol, E-cis,epi-.beta- (J) with the active site of SARS-CoV-2 M<sup>pro</sup> (PDB ID: 6W63); Figure S6: 2D and 3D interactions of Spiro[4,5]dec-6-en-1-ol, 2,6,10,10-tetramethyl (K) and 3.beta-Hydroxy-5-cholen-24-oic acid (L) with the active site of SARS-CoV-2 M<sup>pro</sup> (PDB ID: 6W63); Figure S7: 2D and 3D interactions of Phosphonoacetic acid, 3TMS derivative (M) and Nordazepam, TMS derivative (N) with the active site of SARS-CoV-2 M<sup>pro</sup> (PDB ID: 6W63); Figure S8: 2D and 3D interactions of 2,6-Dihydroxybenzoic acid, 3TMS derivative (O) and aR-Turmerone (P) with the active site of SARS-CoV-2 M<sup>pro</sup> (PDB ID: 6W63); Figure S9: 2D and 3D interactions of (Z)-.gamma.-Atlantone (Q) and Verbenyl angelate, cis- (R) with the active site of SARS-CoV-2 M<sup>pro</sup> (PDB ID: 6W63); Figure S10. 2D and 3D interactions of Tumerone (S) and Dibutyl phthalate (T) with the active site of SARS-CoV-2 M<sup>pro</sup> (PDB ID: 6W63); Figure S11: 2D and 3D interactions of (-)-Globulol (U) and Androstan-17-one, 3-ethyl-3-hydroxy-, (5.alpha) (V) with the active site of SARS-CoV-2 M<sup>pro</sup> (PDB ID: 6W63); Figure S12: 2D and 3D interactions of Yangambin (W) with the active site of SARS-CoV-2 M<sup>pro</sup> (PDB ID: 6W63); Figure S13: 2D and 3D interactions of Nelfinavir (X) and Lopinavir (Y) with the active site of SARS-CoV-2 M<sup>pro</sup> (PDB ID: 6W63).</p><supplementary-material content-type="local-data" id="molecules-25-03936-s001"><media xlink:href="molecules-25-03936-s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, A.R., A.P., M.N.U.C., T.TB.E., and J.S.-G.; methodology, A.R., A.P., S.A.S., and S.K.B.; software, A.R., A.P., and S.A.S.; validation, M.M., A.M.T., M.N.A., and A.S.; formal analysis, A.R., T.B.E., and T.E.T.; investigation, A.R., A.P., T.B.E., and J.S.-G.; resources, J.S.-G.; data curation, A.R., A.P., and M.N.U.C.; writing&#x02014;original draft preparation, A.R., A.P., T.B.E., and J.S.-G.; writing&#x02014;review and editing, M.Z.U., M.D., T.B.E., and J.S.-G.; visualization, A.R., S.K.B., M.M., A.P., and S.A.S.; supervision, T.B.E. and J.S.-G.; project administration, T.E.T., T.B.E., and J.S.-G.; funding acquisition, T.B.E. and J.S.-G. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research received no external funding.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-molecules-25-03936"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Islam</surname><given-names>M.S.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name></person-group><article-title>Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective</article-title><source>Int. J. Biol. Sci.</source><year>2020</year><volume>16</volume><fpage>1708</fpage><pub-id pub-id-type="doi">10.7150/ijbs.45538</pub-id><pub-id pub-id-type="pmid">32226288</pub-id></element-citation></ref><ref id="B2-molecules-25-03936"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chhikara</surname><given-names>B.S.</given-names></name><name><surname>Rathi</surname><given-names>B.</given-names></name><name><surname>Singh</surname><given-names>J.</given-names></name><name><surname>Poonam</surname><given-names>F.N.U.</given-names></name></person-group><article-title>Corona virus SARS-CoV-2 disease COVID-19: Infection, prevention and clinical advances of the prospective chemical drug therapeutics</article-title><source>Chem. Biol. Lett.</source><year>2020</year><volume>7</volume><fpage>63</fpage><lpage>72</lpage></element-citation></ref><ref id="B3-molecules-25-03936"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agbowuro</surname><given-names>A.A.</given-names></name><name><surname>Huston</surname><given-names>W.M.</given-names></name><name><surname>Gamble</surname><given-names>A.B.</given-names></name><name><surname>Tyndall</surname><given-names>J.D.A.</given-names></name></person-group><article-title>Proteases and protease inhibitors in infectious diseases</article-title><source>Med. Res. Rev.</source><year>2018</year><volume>38</volume><fpage>1295</fpage><lpage>1331</lpage><pub-id pub-id-type="doi">10.1002/med.21475</pub-id><pub-id pub-id-type="pmid">29149530</pub-id></element-citation></ref><ref id="B4-molecules-25-03936"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Jin</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Rao</surname><given-names>Z.</given-names></name></person-group><article-title>The Crytal Structure of 2019-NCoV Main Protease in Complex with an Inhibitor N3</article-title><source>RCSB Protein Data Bank</source><year>2020</year></element-citation></ref><ref id="B5-molecules-25-03936"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ullrich</surname><given-names>S.</given-names></name><name><surname>Nitsche</surname><given-names>C.</given-names></name></person-group><article-title>The SARS-CoV-2 main protease as drug target</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2020</year><fpage>127377</fpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2020.127377</pub-id><pub-id pub-id-type="pmid">32738988</pub-id></element-citation></ref><ref id="B6-molecules-25-03936"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziebuhr</surname><given-names>J.</given-names></name><name><surname>Snijder</surname><given-names>E.J.</given-names></name><name><surname>Gorbalenya</surname><given-names>A.E.</given-names></name></person-group><article-title>Virus-encoded proteinases and proteolytic processing in the Nidovirales</article-title><source>J. Gen. Virol.</source><year>2000</year><volume>81</volume><fpage>853</fpage><lpage>879</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-81-4-853</pub-id><pub-id pub-id-type="pmid">10725411</pub-id></element-citation></ref><ref id="B7-molecules-25-03936"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hegyi</surname><given-names>A.</given-names></name><name><surname>Ziebuhr</surname><given-names>J.</given-names></name></person-group><article-title>Conservation of substrate specificities among coronavirus main proteases</article-title><source>J. Gen. Virol.</source><year>2002</year><volume>83</volume><fpage>595</fpage><lpage>599</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-83-3-595</pub-id><pub-id pub-id-type="pmid">11842254</pub-id></element-citation></ref><ref id="B8-molecules-25-03936"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>Q.-S.</given-names></name><name><surname>Wang</surname><given-names>S.-Q.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Wei</surname><given-names>D.-Q.</given-names></name><name><surname>Guo</surname><given-names>H.</given-names></name><name><surname>Sirois</surname><given-names>S.</given-names></name><name><surname>Chou</surname><given-names>K.-C.</given-names></name></person-group><article-title>Polyprotein cleavage mechanism of SARS-CoV M<sup>pro</sup> and chemical modification of the octapeptide</article-title><source>Peptides</source><year>2004</year><volume>25</volume><fpage>1857</fpage><lpage>1864</lpage><pub-id pub-id-type="doi">10.1016/j.peptides.2004.06.018</pub-id><pub-id pub-id-type="pmid">15501516</pub-id></element-citation></ref><ref id="B9-molecules-25-03936"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thiel</surname><given-names>V.</given-names></name><name><surname>Ivanov</surname><given-names>K.A.</given-names></name><name><surname>Putics</surname><given-names>A.</given-names></name><name><surname>Hertzig</surname><given-names>T.</given-names></name><name><surname>Schelle</surname><given-names>B.</given-names></name><name><surname>Bayer</surname><given-names>S.</given-names></name><name><surname>Wei&#x000df;brich</surname><given-names>B.</given-names></name><name><surname>Snijder</surname><given-names>E.J.</given-names></name><name><surname>Rabenau</surname><given-names>H.</given-names></name><name><surname>Doerr</surname><given-names>H.W.</given-names></name><etal/></person-group><article-title>Mechanisms and enzymes involved in SARS coronavirus genome expression</article-title><source>J. Gen. Virol.</source><year>2003</year><volume>84</volume><fpage>2305</fpage><lpage>2315</lpage><pub-id pub-id-type="doi">10.1099/vir.0.19424-0</pub-id><pub-id pub-id-type="pmid">12917450</pub-id></element-citation></ref><ref id="B10-molecules-25-03936"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>H.</given-names></name></person-group><article-title>Drug treatment options for the 2019-new coronavirus (2019-nCoV)</article-title><source>Biosci. Trends</source><year>2020</year><volume>14</volume><fpage>69</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.5582/bst.2020.01020</pub-id><pub-id pub-id-type="pmid">31996494</pub-id></element-citation></ref><ref id="B11-molecules-25-03936"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Peng</surname><given-names>C.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>Z.</given-names></name><name><surname>Mu</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Zhu</surname><given-names>W.</given-names></name></person-group><article-title>Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation</article-title><source>BioRxiv</source><year>2020</year><pub-id pub-id-type="doi">10.1101/2020.01.27.921627</pub-id></element-citation></ref><ref id="B12-molecules-25-03936"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khaerunnisa</surname><given-names>S.</given-names></name><name><surname>Kurniawan</surname><given-names>H.</given-names></name><name><surname>Awaluddin</surname><given-names>R.</given-names></name><name><surname>Suhartati</surname><given-names>S.</given-names></name><name><surname>Soetjipto</surname><given-names>S.</given-names></name></person-group><article-title>Potential Inhibitor of COVID-19 Main Protease (M<sup>pro</sup>) from Several Medicinal Plant Compounds by Molecular Docking Study</article-title><source>Preprints</source><year>2020</year><volume>20944</volume><fpage>1</fpage><lpage>14</lpage></element-citation></ref><ref id="B13-molecules-25-03936"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khanam</surname><given-names>B.H.</given-names></name><name><surname>Rakib</surname><given-names>A.</given-names></name><name><surname>Faiz</surname><given-names>F.B.</given-names></name><name><surname>Uddin</surname><given-names>M.G.</given-names></name><name><surname>Hossain</surname><given-names>M.K.</given-names></name><name><surname>Sultan</surname><given-names>R.A.</given-names></name></person-group><article-title>Highly Anticancer and Moderate Thrombolytic Property of <italic>Accacia rugata</italic> of Mimosaceae Family</article-title><source>J. Plant. Sci.</source><year>2020</year><volume>8</volume><fpage>12</fpage><lpage>16</lpage></element-citation></ref><ref id="B14-molecules-25-03936"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dutta</surname><given-names>T.</given-names></name><name><surname>Paul</surname><given-names>A.</given-names></name><name><surname>Majumder</surname><given-names>M.</given-names></name><name><surname>Sultan</surname><given-names>R.A.</given-names></name><name><surname>Emran</surname><given-names>T.B.</given-names></name></person-group><article-title>Pharmacological evidence for the use of Cissus assamica as a medicinal plant in the management of pain and pyrexia</article-title><source>Biochem. Biophys. Rep.</source><year>2020</year><volume>21</volume><fpage>100715</fpage><pub-id pub-id-type="pmid">31872083</pub-id></element-citation></ref><ref id="B15-molecules-25-03936"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tareq</surname><given-names>A.M.</given-names></name><name><surname>Farhad</surname><given-names>S.</given-names></name><name><surname>Neshar Uddin</surname><given-names>A.B.M.</given-names></name><name><surname>Hoque</surname><given-names>M.</given-names></name><name><surname>Nasrin</surname><given-names>M.S.</given-names></name><name><surname>Uddin</surname><given-names>M.M.R.</given-names></name><name><surname>Hasan</surname><given-names>M.</given-names></name><name><surname>Sultana</surname><given-names>A.</given-names></name><name><surname>Munira</surname><given-names>M.S.</given-names></name><name><surname>Lyzu</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Chemical profiles, pharmacological properties, and in silico studies provide new insights on <italic>Cycas pectinata</italic></article-title><source>Heliyon</source><year>2020</year><volume>6</volume><fpage>e04061</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2020.e04061</pub-id><pub-id pub-id-type="pmid">32529070</pub-id></element-citation></ref><ref id="B16-molecules-25-03936"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shifah</surname><given-names>F.</given-names></name><name><surname>Tareq</surname><given-names>A.M.</given-names></name><name><surname>Sayeed</surname><given-names>M.A.</given-names></name><name><surname>Islam</surname><given-names>M.N.</given-names></name><name><surname>Emran</surname><given-names>T.B.</given-names></name><name><surname>Ullah</surname><given-names>M.A.</given-names></name><name><surname>Mukit</surname><given-names>M.A.</given-names></name><name><surname>Ullah</surname><given-names>A.</given-names></name></person-group><article-title>Antidiarrheal, cytotoxic and thrombolytic activities of methanolic extract of <italic>Hedychium coccineum</italic> leaves</article-title><source>J. Adv. Biotechnol. Experiment. Therap.</source><year>2020</year><volume>11</volume><fpage>12</fpage><pub-id pub-id-type="doi">10.5455/jabet.2020.d110</pub-id></element-citation></ref><ref id="B17-molecules-25-03936"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uddin</surname><given-names>M.Z.</given-names></name><name><surname>Rana</surname><given-names>M.S.</given-names></name><name><surname>Hossain</surname><given-names>S.</given-names></name><name><surname>Ferdous</surname><given-names>S.</given-names></name><name><surname>Dutta</surname><given-names>E.</given-names></name><name><surname>Dutta</surname><given-names>M.</given-names></name><name><surname>Emran</surname><given-names>T.</given-names></name></person-group><article-title>Bin In vivo neuroprotective, antinociceptive, anti-inflammatory potential in Swiss albino mice and in vitro antioxidant and clot lysis activities of fractionated <italic>Holigarna longifolia</italic> Roxb. bark extract</article-title><source>J. Complement. Integr. Med.</source><year>2019</year><volume>17</volume><pub-id pub-id-type="doi">10.1515/jcim-2019-0102</pub-id></element-citation></ref><ref id="B18-molecules-25-03936"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uddin</surname><given-names>M.M.N.</given-names></name><name><surname>Ahmed</surname><given-names>S.</given-names></name><name><surname>Kabir</surname><given-names>M.S.H.</given-names></name><name><surname>Rahman</surname><given-names>M.S.</given-names></name><name><surname>Sultan</surname><given-names>R.A.</given-names></name><name><surname>Emran</surname><given-names>T.</given-names></name></person-group><article-title>Bin In vivo analgesic, anti-inflammatory potential in Swiss albino mice and in vitro thrombolytic activity of hydroalcoholic fruits extract from <italic>Daemonorops robusta</italic> Warb</article-title><source>J. Appl. Pharm. Sci.</source><year>2017</year><volume>7</volume><fpage>104</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.7324/JAPS.2017.70114</pub-id></element-citation></ref><ref id="B19-molecules-25-03936"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahan</surname><given-names>I.</given-names></name><name><surname>Tona</surname><given-names>M.R.</given-names></name><name><surname>Sharmin</surname><given-names>S.</given-names></name><name><surname>Sayeed</surname><given-names>M.A.</given-names></name><name><surname>Tania</surname><given-names>F.Z.</given-names></name><name><surname>Paul</surname><given-names>A.</given-names></name><name><surname>Chy</surname><given-names>M.N.U.</given-names></name><name><surname>Rakib</surname><given-names>A.</given-names></name><name><surname>Emran</surname><given-names>T.B.</given-names></name><name><surname>Simal-Gandara</surname><given-names>J.</given-names></name></person-group><article-title>GC-MS Phytochemical Profiling, Pharmacological Properties, and In Silico Studies of <italic>Chukrasia velutina</italic> Leaves: A Novel Source for Bioactive Agents</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>3536</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25153536</pub-id></element-citation></ref><ref id="B20-molecules-25-03936"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashraf</surname><given-names>M.A.</given-names></name><name><surname>Khatun</surname><given-names>A.</given-names></name><name><surname>Sharmin</surname><given-names>T.</given-names></name><name><surname>Mobin</surname><given-names>F.</given-names></name><name><surname>Tanu</surname><given-names>A.R.</given-names></name><name><surname>Morshed</surname><given-names>T.</given-names></name><name><surname>Fakir</surname><given-names>T.A.</given-names></name><name><surname>Begum</surname><given-names>R.A.</given-names></name><name><surname>Nabi</surname><given-names>A.N.</given-names></name></person-group><article-title>MPDB 1.0: A medicinal plant database of Bangladesh</article-title><source>Bioinformation</source><year>2014</year><volume>10</volume><fpage>384</fpage><lpage>386</lpage><pub-id pub-id-type="pmid">25097384</pub-id></element-citation></ref><ref id="B21-molecules-25-03936"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rakib</surname><given-names>A.</given-names></name><name><surname>Ahmed</surname><given-names>S.</given-names></name><name><surname>Islam</surname><given-names>M.A.</given-names></name><name><surname>Haye</surname><given-names>A.</given-names></name><name><surname>Uddin</surname><given-names>S.M.N.</given-names></name><name><surname>Uddin</surname><given-names>M.M.N.</given-names></name><name><surname>Hossain</surname><given-names>M.K.</given-names></name><name><surname>Paul</surname><given-names>A.</given-names></name><name><surname>Emran</surname><given-names>T.</given-names></name></person-group><article-title>Bin Antipyretic and hepatoprotective potential of <italic>Tinospora crispa</italic> and investigation of possible lead compounds through in silico approaches</article-title><source>Food Sci. Nutr.</source><year>2020</year><volume>8</volume><fpage>547</fpage><lpage>556</lpage><pub-id pub-id-type="doi">10.1002/fsn3.1339</pub-id><pub-id pub-id-type="pmid">31993178</pub-id></element-citation></ref><ref id="B22-molecules-25-03936"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rakib</surname><given-names>A.</given-names></name><name><surname>Ahmed</surname><given-names>S.</given-names></name><name><surname>Islam</surname><given-names>M.A.</given-names></name><name><surname>Uddin</surname><given-names>M.M.N.</given-names></name><name><surname>Paul</surname><given-names>A.</given-names></name><name><surname>Chy</surname><given-names>M.N.U.</given-names></name><name><surname>Emran</surname><given-names>T.B.</given-names></name><name><surname>Seidel</surname><given-names>V.</given-names></name></person-group><article-title>Pharmacological studies on the antinociceptive, anxiolytic and antidepressant activity of <italic>Tinospora crispa</italic></article-title><source>Phyther. Res.</source><year>2020</year><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1002/ptr.6725</pub-id></element-citation></ref><ref id="B23-molecules-25-03936"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niljan</surname><given-names>J.</given-names></name><name><surname>Jaihan</surname><given-names>U.</given-names></name><name><surname>Srichairatanakool</surname><given-names>S.</given-names></name><name><surname>Uthaipibull</surname><given-names>C.</given-names></name><name><surname>Somsak</surname><given-names>V.</given-names></name></person-group><article-title>Antimalarial activity of stem extract of Tinospora crispa against <italic>Plasmodium berghei</italic> infection in mice</article-title><source>J. Heal. Res.</source><year>2014</year><volume>28</volume><fpage>199</fpage><lpage>204</lpage></element-citation></ref><ref id="B24-molecules-25-03936"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gautret</surname><given-names>P.</given-names></name><name><surname>Lagier</surname><given-names>J.-C.</given-names></name><name><surname>Parola</surname><given-names>P.</given-names></name><name><surname>Meddeb</surname><given-names>L.</given-names></name><name><surname>Mailhe</surname><given-names>M.</given-names></name><name><surname>Doudier</surname><given-names>B.</given-names></name><name><surname>Courjon</surname><given-names>J.</given-names></name><name><surname>Giordanengo</surname><given-names>V.</given-names></name><name><surname>Vieira</surname><given-names>V.E.</given-names></name><name><surname>Dupont</surname><given-names>H.T.</given-names></name><etal/></person-group><article-title>Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial</article-title><source>Int. J. Antimicrob. Agents</source><year>2020</year><volume>56</volume><fpage>105949</fpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.105949</pub-id><pub-id pub-id-type="pmid">32205204</pub-id></element-citation></ref><ref id="B25-molecules-25-03936"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colson</surname><given-names>P.</given-names></name><name><surname>Rolain</surname><given-names>J.-M.</given-names></name><name><surname>Lagier</surname><given-names>J.-C.</given-names></name><name><surname>Brouqui</surname><given-names>P.</given-names></name><name><surname>Raoult</surname><given-names>D.</given-names></name></person-group><article-title>Chloroquine and hydroxychloroquine as available weapons to fight COVID-19</article-title><source>Int. J. Antimicrob. Agents</source><year>2020</year><volume>10</volume><fpage>105932</fpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.105932</pub-id></element-citation></ref><ref id="B26-molecules-25-03936"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Direkbusarakom</surname><given-names>S.</given-names></name><name><surname>Herunsalee</surname><given-names>A.</given-names></name><name><surname>Yoshimizu</surname><given-names>M.</given-names></name><name><surname>Ezura</surname><given-names>Y.</given-names></name></person-group><article-title>Antiviral activity of several Thai traditional herb extracts against fish pathogenic viruses</article-title><source>Fish. Pathol.</source><year>1996</year><volume>31</volume><fpage>209</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.3147/jsfp.31.209</pub-id></element-citation></ref><ref id="B27-molecules-25-03936"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saha</surname><given-names>S.</given-names></name><name><surname>Ghosh</surname><given-names>S.</given-names></name></person-group><article-title>Tinospora cordifolia: One plant, many roles</article-title><source>Anc. Sci. Life</source><year>2012</year><volume>31</volume><fpage>151</fpage><pub-id pub-id-type="pmid">23661861</pub-id></element-citation></ref><ref id="B28-molecules-25-03936"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diao</surname><given-names>K.</given-names></name><name><surname>Han</surname><given-names>P.</given-names></name><name><surname>Pang</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name></person-group><article-title>HRCT Imaging Features in Representative Imported Cases of 2019 Novel Coronavirus Pneumonia</article-title><source>Precis. Clin. Med.</source><year>2020</year><volume>3</volume><fpage>9</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1093/pcmedi/pbaa004</pub-id></element-citation></ref><ref id="B29-molecules-25-03936"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>D.</given-names></name><name><surname>Lin</surname><given-names>M.</given-names></name><name><surname>Wei</surname><given-names>L.</given-names></name><name><surname>Xie</surname><given-names>L.</given-names></name><name><surname>Zhu</surname><given-names>G.</given-names></name><name><surname>Dela Cruz</surname><given-names>C.S.</given-names></name><name><surname>Sharma</surname><given-names>L.</given-names></name></person-group><article-title>Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China</article-title><source>JAMA-J. Am. Med. Assoc.</source><year>2020</year><volume>323</volume><fpage>1092</fpage><lpage>1093</lpage><pub-id pub-id-type="doi">10.1001/jama.2020.1623</pub-id></element-citation></ref><ref id="B30-molecules-25-03936"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holshue</surname><given-names>M.L.</given-names></name><name><surname>DeBolt</surname><given-names>C.</given-names></name><name><surname>Lindquist</surname><given-names>S.</given-names></name><name><surname>Lofy</surname><given-names>K.H.</given-names></name><name><surname>Wiesman</surname><given-names>J.</given-names></name><name><surname>Bruce</surname><given-names>H.</given-names></name><name><surname>Spitters</surname><given-names>C.</given-names></name><name><surname>Ericson</surname><given-names>K.</given-names></name><name><surname>Wilkerson</surname><given-names>S.</given-names></name><name><surname>Tural</surname><given-names>A.</given-names></name><etal/></person-group><article-title>First case of 2019 novel coronavirus in the United States</article-title><source>N. Engl. J. Med.</source><year>2020</year><volume>382</volume><fpage>1708</fpage><lpage>1720</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2001191</pub-id><pub-id pub-id-type="pmid">32109013</pub-id></element-citation></ref><ref id="B31-molecules-25-03936"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Gayle</surname><given-names>A.A.</given-names></name><name><surname>Wilder-Smith</surname><given-names>A.</given-names></name><name><surname>Rockl&#x000f6;v</surname><given-names>J.</given-names></name></person-group><article-title>The reproductive number of COVID-19 is higher compared to SARS coronavirus</article-title><source>J. Travel Med.</source><year>2020</year><pub-id pub-id-type="doi">10.1093/jtm/taaa021</pub-id></element-citation></ref><ref id="B32-molecules-25-03936"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahase</surname><given-names>E.</given-names></name></person-group><article-title>Coronavirus: Covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate</article-title><source>BMJ</source><year>2020</year><volume>368</volume><fpage>m641</fpage><pub-id pub-id-type="doi">10.1136/bmj.m641</pub-id><pub-id pub-id-type="pmid">32071063</pub-id></element-citation></ref><ref id="B33-molecules-25-03936"><label>33.</label><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>J.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Bao</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>P.</given-names></name></person-group><article-title>Exploring the Active Compounds of Traditional Mongolian Medicine Agsirga in Intervention of Novel Coronavirus (2019-nCoV) Based on HPLC-Q-Exactive-MS/MS and Molecular Docking Method</article-title><year>2020</year><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://chemrxiv.org/articles/Exploring_the_Active_Compounds_of_Traditional_Mongolian_Medicine_Agsirga_in_Intervention_of_Novel_Coronavirus_2019-nCoV_Based_on_HPLC-Q-Exactive-MS_MS_and_Molecular_Docking_Method/11955273">https://chemrxiv.org/articles/Exploring_the_Active_Compounds_of_Traditional_Mongolian_Medicine_Agsirga_in_Intervention_of_Novel_Coronavirus_2019-nCoV_Based_on_HPLC-Q-Exactive-MS_MS_and_Molecular_Docking_Method/11955273</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-08-10">(accessed on 10 August 2020)</date-in-citation></element-citation></ref><ref id="B34-molecules-25-03936"><label>34.</label><element-citation publication-type="gov"><person-group person-group-type="author"><name><surname>Rakib</surname><given-names>A.</given-names></name><name><surname>Sami</surname><given-names>S.A.</given-names></name><name><surname>Islam</surname><given-names>M.A.</given-names></name><name><surname>Ahmed</surname><given-names>S.</given-names></name><name><surname>Faiz</surname><given-names>F.B.</given-names></name><name><surname>Khanam</surname><given-names>B.H.</given-names></name><name><surname>Marma</surname><given-names>K.K.S.</given-names></name><name><surname>Rahman</surname><given-names>M.</given-names></name><name><surname>Uddin</surname><given-names>M.M.N.</given-names></name><name><surname>Emran</surname><given-names>T.B.</given-names></name><etal/></person-group><article-title>Epitope-based Immunoinformatics Approach on Nucleocapsid Protein of Severe Acute Respiratory Syndrome-Coronavirus-2</article-title><year>2020</year><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423576/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423576/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-08-10">(accessed on 10 August 2020)</date-in-citation></element-citation></ref><ref id="B35-molecules-25-03936"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oyebode</surname><given-names>O.</given-names></name><name><surname>Kandala</surname><given-names>N.-B.</given-names></name><name><surname>Chilton</surname><given-names>P.J.</given-names></name><name><surname>Lilford</surname><given-names>R.J.</given-names></name></person-group><article-title>Use of traditional medicine in middle-income countries: A WHO-SAGE study</article-title><source>Health Policy Plan.</source><year>2016</year><volume>31</volume><fpage>984</fpage><lpage>991</lpage><pub-id pub-id-type="doi">10.1093/heapol/czw022</pub-id><pub-id pub-id-type="pmid">27033366</pub-id></element-citation></ref><ref id="B36-molecules-25-03936"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gwynn</surname><given-names>J.</given-names></name><name><surname>Hylands</surname><given-names>P.J.</given-names></name></person-group><article-title>Plants as a source of new medicines</article-title><source>Drug Discov.</source><year>2000</year><volume>55</volume><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.researchgate.net/profile/Jennie_Gwynn2/publication/325417739_Plants_as_a_Source_of_New_Medicines_&#x02019;Reproduced_with_kind_permission_of_Drug_Discovery_World_Summer_2000_Vol_1_No_1&#x02019;/links/5b7bf331a6fdcc5f8b586555/Plants-as-a-Source-of-New-Medicines-Reproduced-with-kind-permission-of-Drug-Discovery-World-Summer-2000-Vol-1-No-1.pdf">https://www.researchgate.net/profile/Jennie_Gwynn2/publication/325417739_Plants_as_a_Source_of_New_Medicines_&#x02019;Reproduced_with_kind_permission_of_Drug_Discovery_World_Summer_2000_Vol_1_No_1&#x02019;/links/5b7bf331a6fdcc5f8b586555/Plants-as-a-Source-of-New-Medicines-Reproduced-with-kind-permission-of-Drug-Discovery-World-Summer-2000-Vol-1-No-1.pdf</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-08-10">(accessed on 10 August 2020)</date-in-citation></element-citation></ref><ref id="B37-molecules-25-03936"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al Mahmud</surname><given-names>Z.</given-names></name><name><surname>Bachar</surname><given-names>S.C.</given-names></name><name><surname>Hasan</surname><given-names>C.M.</given-names></name><name><surname>Emran</surname><given-names>T.B.</given-names></name><name><surname>Qais</surname><given-names>N.</given-names></name><name><surname>Uddin</surname><given-names>M.M.N.</given-names></name></person-group><article-title>Phytochemical investigations and antioxidant potential of roots of <italic>Leea macrophylla</italic> (Roxb.)</article-title><source>BMC Res. Notes</source><year>2017</year><volume>10</volume><elocation-id>245</elocation-id><pub-id pub-id-type="doi">10.1186/s13104-017-2503-2</pub-id><pub-id pub-id-type="pmid">28683831</pub-id></element-citation></ref><ref id="B38-molecules-25-03936"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al Mahmud</surname><given-names>Z.</given-names></name><name><surname>Emran</surname><given-names>T.B.</given-names></name><name><surname>Qais</surname><given-names>N.</given-names></name><name><surname>Bachar</surname><given-names>S.C.</given-names></name><name><surname>Sarker</surname><given-names>M.</given-names></name><name><surname>Uddin</surname><given-names>M.M.N.</given-names></name></person-group><article-title>Evaluation of analgesic, anti-inflammatory, thrombolytic and hepatoprotective activities of roots of <italic>Premna esculenta</italic> (Roxb)</article-title><source>J. Basic Clin. Physiol. Pharmacol.</source><year>2016</year><volume>27</volume><fpage>63</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1515/jbcpp-2015-0056</pub-id><pub-id pub-id-type="pmid">26457773</pub-id></element-citation></ref><ref id="B39-molecules-25-03936"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emran</surname><given-names>T.</given-names></name><name><surname>E.-Mowla</surname><given-names>T.</given-names></name><name><surname>Ahmed</surname><given-names>S.</given-names></name><name><surname>Zahan</surname><given-names>S.</given-names></name><name><surname>Rakib</surname><given-names>A.</given-names></name><name><surname>Hasan</surname><given-names>M.</given-names></name><name><surname>Amin</surname><given-names>M.</given-names></name><name><surname>Mow</surname><given-names>T.</given-names></name><name><surname>Uddin</surname><given-names>M.</given-names></name></person-group><article-title>Sedative, Anxiolytic, Antinociceptive, Anti-inflammatory and Antipyretic Effects of a Chloroform Extract from the Leaves of <italic>Urena sinuata</italic> in Rodents</article-title><source>J. Appl. Life Sci. Int.</source><year>2018</year><volume>16</volume><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.9734/JALSI/2018/39073</pub-id></element-citation></ref><ref id="B40-molecules-25-03936"><label>40.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>H.K.</given-names></name><name><surname>Wolff</surname><given-names>P.M.</given-names></name></person-group><article-title>New Natural Products and Plant</article-title><source>Drugs with Pharmacological, Biological or Therapeutical Activity: Proceedings of the First International Congress on Medicinal Plant</source><person-group person-group-type="editor"><name><surname>Farnsworth</surname><given-names>N.R.</given-names></name><name><surname>Bingel</surname><given-names>A.S.</given-names></name></person-group><publisher-name>Springer Science &#x00026; Business Media</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>2012</year><fpage>6</fpage><lpage>10</lpage></element-citation></ref><ref id="B41-molecules-25-03936"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emran</surname><given-names>T.B.</given-names></name><name><surname>Rahman</surname><given-names>M.A.</given-names></name><name><surname>Uddin</surname><given-names>M.M.N.</given-names></name><name><surname>Rahman</surname><given-names>M.M.</given-names></name><name><surname>Uddin</surname><given-names>M.Z.</given-names></name><name><surname>Dash</surname><given-names>R.</given-names></name><name><surname>Layzu</surname><given-names>C.</given-names></name></person-group><article-title>Effects of organic extracts and their different fractions of five Bangladeshi plants on in vitro thrombolysis</article-title><source>BMC Complement. Altern. Med.</source><year>2015</year><volume>15</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1186/s12906-015-0643-2</pub-id><pub-id pub-id-type="pmid">25617057</pub-id></element-citation></ref><ref id="B42-molecules-25-03936"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasanthi</surname><given-names>H.</given-names></name><name><surname>ShriShriMal</surname><given-names>N.</given-names></name><name><surname>Das</surname><given-names>D.K.</given-names></name></person-group><article-title>Phytochemicals from plants to combat cardiovascular disease</article-title><source>Curr. Med. Chem.</source><year>2012</year><volume>19</volume><fpage>2242</fpage><lpage>2251</lpage><pub-id pub-id-type="doi">10.2174/092986712800229078</pub-id><pub-id pub-id-type="pmid">22414106</pub-id></element-citation></ref><ref id="B43-molecules-25-03936"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>K.W.</given-names></name><name><surname>Bode</surname><given-names>A.M.</given-names></name><name><surname>Dong</surname><given-names>Z.</given-names></name></person-group><article-title>Molecular targets of phytochemicals for cancer prevention</article-title><source>Nat. Rev. Cancer</source><year>2011</year><volume>11</volume><fpage>211</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1038/nrc3017</pub-id><pub-id pub-id-type="pmid">21326325</pub-id></element-citation></ref><ref id="B44-molecules-25-03936"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>R.</given-names></name><name><surname>Arif</surname><given-names>T.</given-names></name><name><surname>Khan</surname><given-names>I.</given-names></name><name><surname>Sharma</surname><given-names>P.</given-names></name></person-group><article-title>Phytochemicals in antidiabetic drug discovery</article-title><source>J. Biomed. Ther. Sci.</source><year>2014</year><volume>1</volume><fpage>1</fpage><lpage>33</lpage></element-citation></ref><ref id="B45-molecules-25-03936"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korkina</surname><given-names>L.</given-names></name><name><surname>Kostyuk</surname><given-names>V.</given-names></name><name><surname>Potapovich</surname><given-names>A.</given-names></name><name><surname>Mayer</surname><given-names>W.</given-names></name><name><surname>Talib</surname><given-names>N.</given-names></name><name><surname>De Luca</surname><given-names>C.</given-names></name></person-group><article-title>Secondary Plant Metabolites for Sun Protective Cosmetics: From Pre-Selection to Product Formulation</article-title><source>Cosmetics</source><year>2018</year><volume>5</volume><elocation-id>32</elocation-id><pub-id pub-id-type="doi">10.3390/cosmetics5020032</pub-id></element-citation></ref><ref id="B46-molecules-25-03936"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sermakkani</surname><given-names>M.</given-names></name><name><surname>Thangapandian</surname><given-names>V.</given-names></name></person-group><article-title>GC-MS analysis of <italic>Cassia italica</italic> leaf methanol extract</article-title><source>Asian, J. Pharm. Clin. Res.</source><year>2012</year><volume>5</volume><fpage>90</fpage><lpage>94</lpage></element-citation></ref><ref id="B47-molecules-25-03936"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barua</surname><given-names>N.</given-names></name><name><surname>Aziz</surname><given-names>M.A.I.</given-names></name><name><surname>Tareq</surname><given-names>A.M.</given-names></name><name><surname>Sayeed</surname><given-names>M.A.</given-names></name><name><surname>Alam</surname><given-names>N.</given-names></name><name><surname>ul Alam</surname><given-names>N.</given-names></name><name><surname>Uddin</surname><given-names>M.A.</given-names></name><name><surname>Lyzu</surname><given-names>C.</given-names></name><name><surname>Emran</surname><given-names>T.B.</given-names></name></person-group><article-title>In vivo and in vitro evaluation of pharmacological activities of <italic>Adenia trilobata</italic> (Roxb.)</article-title><source>Biochem. Biophys. Rep.</source><year>2020</year><volume>23</volume><fpage>100772</fpage><pub-id pub-id-type="doi">10.1016/j.bbrep.2020.100772</pub-id><pub-id pub-id-type="pmid">32551370</pub-id></element-citation></ref><ref id="B48-molecules-25-03936"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>ul Qamar</surname><given-names>M.T.</given-names></name><name><surname>Alqahtani</surname><given-names>S.M.</given-names></name><name><surname>Alamri</surname><given-names>M.A.</given-names></name><name><surname>Chen</surname><given-names>L.-L.</given-names></name></person-group><article-title>Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants</article-title><source>J. Pharm. Anal.</source><year>2020</year><pub-id pub-id-type="doi">10.1016/j.jpha.2020.03.009</pub-id></element-citation></ref><ref id="B49-molecules-25-03936"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adem</surname><given-names>S.</given-names></name><name><surname>Eyupoglu</surname><given-names>V.</given-names></name><name><surname>Sarfraz</surname><given-names>I.</given-names></name><name><surname>Rasul</surname><given-names>A.</given-names></name><name><surname>Ali</surname><given-names>M.</given-names></name></person-group><article-title>Identification of potent COVID-19 main protease (Mpro) inhibitors from natural polyphenols: An in silico strategy unveils a hope against CORONA</article-title><source>Preprints</source><year>2020</year><fpage>2020030333</fpage><pub-id pub-id-type="doi">10.20944/preprints202003.0333.v1</pub-id></element-citation></ref><ref id="B50-molecules-25-03936"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phoebe Chen</surname><given-names>Y.-P.</given-names></name><name><surname>Chen</surname><given-names>F.</given-names></name></person-group><article-title>Identifying targets for drug discovery using bioinformatics</article-title><source>Expert Opin. Ther. Targets</source><year>2008</year><volume>12</volume><fpage>383</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1517/14728222.12.4.383</pub-id><pub-id pub-id-type="pmid">18348676</pub-id></element-citation></ref><ref id="B51-molecules-25-03936"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>S.</given-names></name><name><surname>Rakib</surname><given-names>A.</given-names></name><name><surname>Islam</surname><given-names>M.A.</given-names></name><name><surname>Khanam</surname><given-names>B.H.</given-names></name><name><surname>Faiz</surname><given-names>F.B.</given-names></name><name><surname>Paul</surname><given-names>A.</given-names></name><name><surname>Chy</surname><given-names>M.N.U.</given-names></name><name><surname>Bhuiya</surname><given-names>N.M.M.A.</given-names></name><name><surname>Uddin</surname><given-names>M.M.N.</given-names></name><name><surname>Ullah</surname><given-names>S.M.A.</given-names></name><etal/></person-group><article-title>In vivo and in vitro pharmacological activities of <italic>Tacca integrifolia</italic> rhizome and investigation of possible lead compounds against breast cancer through in silico approaches</article-title><source>Clin. Phytosci.</source><year>2019</year><volume>5</volume><fpage>36</fpage><pub-id pub-id-type="doi">10.1186/s40816-019-0127-x</pub-id></element-citation></ref><ref id="B52-molecules-25-03936"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brooijmans</surname><given-names>N.</given-names></name><name><surname>Kuntz</surname><given-names>I.D.</given-names></name></person-group><article-title>Molecular recognition and docking algorithms</article-title><source>Annu. Rev. Biophys. Biomol. Struct.</source><year>2003</year><volume>32</volume><fpage>335</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1146/annurev.biophys.32.110601.142532</pub-id><pub-id pub-id-type="pmid">12574069</pub-id></element-citation></ref><ref id="B53-molecules-25-03936"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rakib</surname><given-names>A.</given-names></name><name><surname>Sami</surname><given-names>S.A.</given-names></name><name><surname>Mimi</surname><given-names>N.J.</given-names></name><name><surname>Chowdhury</surname><given-names>M.M.</given-names></name><name><surname>Eva</surname><given-names>T.A.</given-names></name><name><surname>Nainu</surname><given-names>F.</given-names></name><name><surname>Paul</surname><given-names>A.</given-names></name><name><surname>Shahriar</surname><given-names>A.</given-names></name><name><surname>Tareq</surname><given-names>A.M.</given-names></name><name><surname>Emon</surname><given-names>N.U.</given-names></name><etal/></person-group><article-title>Immunoinformatics-guided design of an epitope-based vaccine against severe acute respiratory syndrome coronavirus 2 spike glycoprotein</article-title><source>Comput. Biol. Med.</source><year>2020</year><volume>124</volume><fpage>103967</fpage><pub-id pub-id-type="doi">10.1016/j.compbiomed.2020.103967</pub-id><pub-id pub-id-type="pmid">32828069</pub-id></element-citation></ref><ref id="B54-molecules-25-03936"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>N.</given-names></name><name><surname>Matsuyama</surname><given-names>S.</given-names></name><name><surname>Hoshino</surname><given-names>T.</given-names></name><name><surname>Yamamoto</surname><given-names>N.</given-names></name></person-group><article-title>Nelfinavir inhibits replication of severe acute respiratory syndrome coronavirus 2 in vitro</article-title><source>BioRxiv</source><year>2020</year><pub-id pub-id-type="doi">10.1101/2020.04.06.026476</pub-id></element-citation></ref><ref id="B55-molecules-25-03936"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>N.</given-names></name><name><surname>Yang</surname><given-names>R.</given-names></name><name><surname>Yoshinaka</surname><given-names>Y.</given-names></name><name><surname>Amari</surname><given-names>S.</given-names></name><name><surname>Nakano</surname><given-names>T.</given-names></name><name><surname>Cinatl</surname><given-names>J.</given-names></name><name><surname>Rabenau</surname><given-names>H.</given-names></name><name><surname>Doerr</surname><given-names>H.W.</given-names></name><name><surname>Hunsmann</surname><given-names>G.</given-names></name><name><surname>Otaka</surname><given-names>A.</given-names></name><etal/></person-group><article-title>HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2004</year><volume>318</volume><fpage>719</fpage><lpage>725</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2004.04.083</pub-id><pub-id pub-id-type="pmid">15144898</pub-id></element-citation></ref><ref id="B56-molecules-25-03936"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>C.K.</given-names></name><name><surname>Seong</surname><given-names>M.-W.</given-names></name><name><surname>Choi</surname><given-names>S.-J.</given-names></name><name><surname>Kim</surname><given-names>T.S.</given-names></name><name><surname>Choe</surname><given-names>P.G.</given-names></name><name><surname>Song</surname><given-names>S.H.</given-names></name><name><surname>Kim</surname><given-names>N.-J.</given-names></name><name><surname>Park</surname><given-names>W.B.</given-names></name><name><surname>Oh</surname><given-names>M.</given-names></name></person-group><article-title>In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses</article-title><source>Korean J. Intern. Med.</source><year>2020</year><volume>35</volume><fpage>728</fpage><lpage>787</lpage><pub-id pub-id-type="doi">10.3904/kjim.2020.157</pub-id></element-citation></ref><ref id="B57-molecules-25-03936"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goyal</surname><given-names>B.</given-names></name><name><surname>Goyal</surname><given-names>D.</given-names></name></person-group><article-title>Targeting the dimerization of main protease of coronaviruses: A potential broad-spectrum therapeutic strategy</article-title><source>ACS Comb. Sci.</source><year>2020</year><volume>22</volume><fpage>297</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1021/acscombsci.0c00058</pub-id><pub-id pub-id-type="pmid">32402186</pub-id></element-citation></ref><ref id="B58-molecules-25-03936"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muramatsu</surname><given-names>T.</given-names></name><name><surname>Takemoto</surname><given-names>C.</given-names></name><name><surname>Kim</surname><given-names>Y.-T.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Nishii</surname><given-names>W.</given-names></name><name><surname>Terada</surname><given-names>T.</given-names></name><name><surname>Shirouzu</surname><given-names>M.</given-names></name><name><surname>Yokoyama</surname><given-names>S.</given-names></name></person-group><article-title>SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2016</year><volume>113</volume><fpage>12997</fpage><lpage>13002</lpage><pub-id pub-id-type="doi">10.1073/pnas.1601327113</pub-id><pub-id pub-id-type="pmid">27799534</pub-id></element-citation></ref><ref id="B59-molecules-25-03936"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>M.-F.</given-names></name><name><surname>Kuo</surname><given-names>C.-J.</given-names></name><name><surname>Chang</surname><given-names>K.-T.</given-names></name><name><surname>Chang</surname><given-names>H.-C.</given-names></name><name><surname>Chou</surname><given-names>C.-C.</given-names></name><name><surname>Ko</surname><given-names>T.-P.</given-names></name><name><surname>Shr</surname><given-names>H.-L.</given-names></name><name><surname>Chang</surname><given-names>G.-G.</given-names></name><name><surname>Wang</surname><given-names>A.H.-J.</given-names></name><name><surname>Liang</surname><given-names>P.-H.</given-names></name></person-group><article-title>Mechanism of the maturation process of SARS-CoV 3CL protease</article-title><source>J. Biol. Chem.</source><year>2005</year><volume>280</volume><fpage>31257</fpage><lpage>31266</lpage><pub-id pub-id-type="doi">10.1074/jbc.M502577200</pub-id><pub-id pub-id-type="pmid">15788388</pub-id></element-citation></ref><ref id="B60-molecules-25-03936"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volkamer</surname><given-names>A.</given-names></name><name><surname>Kuhn</surname><given-names>D.</given-names></name><name><surname>Rippmann</surname><given-names>F.</given-names></name><name><surname>Rarey</surname><given-names>M.</given-names></name></person-group><article-title>DoGSiteScorer: A web server for automatic binding site prediction, analysis and druggability assessment</article-title><source>Bioinformatics</source><year>2012</year><volume>28</volume><fpage>2074</fpage><lpage>2075</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts310</pub-id><pub-id pub-id-type="pmid">22628523</pub-id></element-citation></ref><ref id="B61-molecules-25-03936"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipinski</surname><given-names>C.A.</given-names></name><name><surname>Lombardo</surname><given-names>F.</given-names></name><name><surname>Dominy</surname><given-names>B.W.</given-names></name><name><surname>Feeney</surname><given-names>P.J.</given-names></name></person-group><article-title>Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</article-title><source>Adv. Drug Deliv. Rev.</source><year>1997</year><volume>23</volume><fpage>3</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/S0169-409X(96)00423-1</pub-id></element-citation></ref><ref id="B62-molecules-25-03936"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lubomirov</surname><given-names>R.</given-names></name><name><surname>di Iulio</surname><given-names>J.</given-names></name><name><surname>Fayet</surname><given-names>A.</given-names></name><name><surname>Colombo</surname><given-names>S.</given-names></name><name><surname>Martinez</surname><given-names>R.</given-names></name><name><surname>Marzolini</surname><given-names>C.</given-names></name><name><surname>Furrer</surname><given-names>H.</given-names></name><name><surname>Vernazza</surname><given-names>P.</given-names></name><name><surname>Calmy</surname><given-names>A.</given-names></name><name><surname>Cavassini</surname><given-names>M.</given-names></name><etal/></person-group><article-title>ADME pharmacogenetics: Investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir</article-title><source>Pharmacogenet. Genomics</source><year>2010</year><volume>20</volume><fpage>217</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1097/FPC.0b013e328336eee4</pub-id><pub-id pub-id-type="pmid">20139798</pub-id></element-citation></ref><ref id="B63-molecules-25-03936"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friesner</surname><given-names>R.A.</given-names></name><name><surname>Murphy</surname><given-names>R.B.</given-names></name><name><surname>Repasky</surname><given-names>M.P.</given-names></name><name><surname>Frye</surname><given-names>L.L.</given-names></name><name><surname>Greenwood</surname><given-names>J.R.</given-names></name><name><surname>Halgren</surname><given-names>T.A.</given-names></name><name><surname>Sanschagrin</surname><given-names>P.C.</given-names></name><name><surname>Mainz</surname><given-names>D.T.</given-names></name></person-group><article-title>Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes</article-title><source>J. Med. Chem.</source><year>2006</year><volume>49</volume><fpage>6177</fpage><lpage>6196</lpage><pub-id pub-id-type="doi">10.1021/jm051256o</pub-id><pub-id pub-id-type="pmid">17034125</pub-id></element-citation></ref><ref id="B64-molecules-25-03936"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friesner</surname><given-names>R.A.</given-names></name><name><surname>Banks</surname><given-names>J.L.</given-names></name><name><surname>Murphy</surname><given-names>R.B.</given-names></name><name><surname>Halgren</surname><given-names>T.A.</given-names></name><name><surname>Klicic</surname><given-names>J.J.</given-names></name><name><surname>Mainz</surname><given-names>D.T.</given-names></name><name><surname>Repasky</surname><given-names>M.P.</given-names></name><name><surname>Knoll</surname><given-names>E.H.</given-names></name><name><surname>Shelley</surname><given-names>M.</given-names></name><name><surname>Perry</surname><given-names>J.K.</given-names></name><etal/></person-group><article-title>Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy</article-title><source>J. Med. Chem.</source><year>2004</year><volume>47</volume><fpage>1739</fpage><lpage>1749</lpage><pub-id pub-id-type="doi">10.1021/jm0306430</pub-id><pub-id pub-id-type="pmid">15027865</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="molecules-25-03936-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Total ionic chromatogram (TIC) of methanolic extract of <italic>T. crispa</italic> whole plants by GC-MS.</p></caption><graphic xlink:href="molecules-25-03936-g001"/></fig><fig id="molecules-25-03936-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Chemical structure of (<bold>A</bold>) (&#x02212;)-Globulol; (<bold>B</bold>) 3.beta-Hydroxy-5-cholen-24-oic acid; (<bold>C</bold>) Androstan-17-one, 3-ethyl-3-hydroxy-, 5; (<bold>D</bold>) Benzeneethanamine; (<bold>E</bold>) Camphenol; (<bold>F</bold>) Imidazolidin-4-one, 2-imino-1-(4-methoxy-6-dimethylamino-1,3,5-triazin-2-yl); (<bold>G</bold>) Nordazepam, TMS derivative; (<bold>H</bold>) Spiro[4,5]dec-6-en-1-ol, 2,6,10,10-tetramethyl; (<bold>I</bold>) Yangambin (structures are drawn using ChemDraw Professional version 16).</p></caption><graphic xlink:href="molecules-25-03936-g002"/></fig><fig id="molecules-25-03936-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Molecular docking interaction between the SARS-CoV-2 M<sup>pro</sup> and imidazolidin-4-one, 2-imino-1-(4-methoxy-6-dimethylamino-1,3,5-triazin-2-yl). The ligand in the active site is shown in purple color and the ligand interacting with the residues is shown in blue color, green color illustrates the residues forming hydrogen bonds, and white color illustrates the residues with carbon&#x02013;hydrogen interaction.</p></caption><graphic xlink:href="molecules-25-03936-g003"/></fig><fig id="molecules-25-03936-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Molecular docking interaction between the SARS-CoV-2 M<sup>pro</sup> and spiro[4,5]dec-6-en-1-ol, 2,6,10,10-tetramethyl. Ligand in the active site is shown in purple color, and ligand interacting with the residues are shown in blue color, pink color illustrated the residues with hydrophobic (pi-pi/pi-alkyl) stacking.</p></caption><graphic xlink:href="molecules-25-03936-g004"/></fig><fig id="molecules-25-03936-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Molecular docking interaction between the SARS-CoV-2 M<sup>pro</sup> and 3.beta-Hydroxy-5-cholen-24-oic acid ligand in the active site is shown in purple color, and ligand interacting with the residues is shown in blue color, green color illustrates the residues forming hydrogen bonds, pink color illustrates the residues with hydrophobic (pi-pi/pi-alkyl) stacking, and white color illustrates the residues with carbon-hydrogen interaction.</p></caption><graphic xlink:href="molecules-25-03936-g005"/></fig><table-wrap id="molecules-25-03936-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-03936-t001_Table 1</object-id><label>Table 1</label><caption><p>Quantitative compounds identified from methanol extract of <italic>T. crispa</italic> by GC-MS analysis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound Name</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Retention Time</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>m</italic>/<italic>z</italic></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Area</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PA (%)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Benzeneethanamine</td><td align="center" valign="middle" rowspan="1" colspan="1">10.083</td><td align="center" valign="middle" rowspan="1" colspan="1">73.00</td><td align="center" valign="middle" rowspan="1" colspan="1">3196250</td><td align="center" valign="middle" rowspan="1" colspan="1">0.106518</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Camphenol</td><td align="center" valign="middle" rowspan="1" colspan="1">13.761</td><td align="center" valign="middle" rowspan="1" colspan="1">107.00</td><td align="center" valign="middle" rowspan="1" colspan="1">431753</td><td align="center" valign="middle" rowspan="1" colspan="1">0.014389</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Strophanthidin</td><td align="center" valign="middle" rowspan="1" colspan="1">22.159</td><td align="center" valign="middle" rowspan="1" colspan="1">79.00</td><td align="center" valign="middle" rowspan="1" colspan="1">334706</td><td align="center" valign="middle" rowspan="1" colspan="1">0.011154</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Retinal</td><td align="center" valign="middle" rowspan="1" colspan="1">22.159</td><td align="center" valign="middle" rowspan="1" colspan="1">79.00</td><td align="center" valign="middle" rowspan="1" colspan="1">334706</td><td align="center" valign="middle" rowspan="1" colspan="1">0.011154</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Trans-Geranylgeraniol</td><td align="center" valign="middle" rowspan="1" colspan="1">24.911</td><td align="center" valign="middle" rowspan="1" colspan="1">69.00</td><td align="center" valign="middle" rowspan="1" colspan="1">4724235</td><td align="center" valign="middle" rowspan="1" colspan="1">0.15744</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3,4-Dihydroxymandelic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">17.261</td><td align="center" valign="middle" rowspan="1" colspan="1">73.00</td><td align="center" valign="middle" rowspan="1" colspan="1">2174852</td><td align="center" valign="middle" rowspan="1" colspan="1">0.072479</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Imidazolidin-4-one, 2-imino-1-(4-methoxy-6-dimethylamino-1,3,5-triazin-2-yl)</td><td align="center" valign="middle" rowspan="1" colspan="1">25.586</td><td align="center" valign="middle" rowspan="1" colspan="1">251.00</td><td align="center" valign="middle" rowspan="1" colspan="1">4374165</td><td align="center" valign="middle" rowspan="1" colspan="1">0.145774</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cholest-22-ene-21-ol, 3,5-dehydro-6-methoxy</td><td align="center" valign="middle" rowspan="1" colspan="1">25.771</td><td align="center" valign="middle" rowspan="1" colspan="1">95.00</td><td align="center" valign="middle" rowspan="1" colspan="1">5058177</td><td align="center" valign="middle" rowspan="1" colspan="1">0.168569</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">d-Mannitol, 1-O-(16-hydroxyhexadecyl)-</td><td align="center" valign="middle" rowspan="1" colspan="1">26.431</td><td align="center" valign="middle" rowspan="1" colspan="1">207.00</td><td align="center" valign="middle" rowspan="1" colspan="1">153759</td><td align="center" valign="middle" rowspan="1" colspan="1">0.005124</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Heneicosanoic acid, methyl ester</td><td align="center" valign="middle" rowspan="1" colspan="1">26.431</td><td align="center" valign="middle" rowspan="1" colspan="1">207.00</td><td align="center" valign="middle" rowspan="1" colspan="1">153759</td><td align="center" valign="middle" rowspan="1" colspan="1">0.005124</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Gorgost-5-en-3-ol, (3.beta)-, TMS derivative</td><td align="center" valign="middle" rowspan="1" colspan="1">26.431</td><td align="center" valign="middle" rowspan="1" colspan="1">207.00</td><td align="center" valign="middle" rowspan="1" colspan="1">153759</td><td align="center" valign="middle" rowspan="1" colspan="1">0.005124</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Retinol</td><td align="center" valign="middle" rowspan="1" colspan="1">26.414</td><td align="center" valign="middle" rowspan="1" colspan="1">91.00</td><td align="center" valign="middle" rowspan="1" colspan="1">1957701</td><td align="center" valign="middle" rowspan="1" colspan="1">0.065242</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Octacosanol</td><td align="center" valign="middle" rowspan="1" colspan="1">27.969</td><td align="center" valign="middle" rowspan="1" colspan="1">97.00</td><td align="center" valign="middle" rowspan="1" colspan="1">3033614</td><td align="center" valign="middle" rowspan="1" colspan="1">0.101098</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Alpha-Santalol</td><td align="center" valign="middle" rowspan="1" colspan="1">28.532</td><td align="center" valign="middle" rowspan="1" colspan="1">94.00</td><td align="center" valign="middle" rowspan="1" colspan="1">3133161</td><td align="center" valign="middle" rowspan="1" colspan="1">0.104416</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Santalol, E-cis,epi-beta-</td><td align="center" valign="middle" rowspan="1" colspan="1">28.532</td><td align="center" valign="middle" rowspan="1" colspan="1">94.00</td><td align="center" valign="middle" rowspan="1" colspan="1">3133161</td><td align="center" valign="middle" rowspan="1" colspan="1">0.104416</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Spiro[4,5]dec-6-en-1-ol, 2,6,10,10-tetramethyl</td><td align="center" valign="middle" rowspan="1" colspan="1">28.532</td><td align="center" valign="middle" rowspan="1" colspan="1">94.00</td><td align="center" valign="middle" rowspan="1" colspan="1">3133161</td><td align="center" valign="middle" rowspan="1" colspan="1">0.104416</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Campesterol</td><td align="center" valign="middle" rowspan="1" colspan="1">29.551</td><td align="center" valign="middle" rowspan="1" colspan="1">207.00</td><td align="center" valign="middle" rowspan="1" colspan="1">243053</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0081</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cholesterol</td><td align="center" valign="middle" rowspan="1" colspan="1">29.551</td><td align="center" valign="middle" rowspan="1" colspan="1">207.00</td><td align="center" valign="middle" rowspan="1" colspan="1">243053</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0081</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">9,19-Cyclocholestan-3-ol, 14-methyl-, (3.beta)</td><td align="center" valign="middle" rowspan="1" colspan="1">29.551</td><td align="center" valign="middle" rowspan="1" colspan="1">207.00</td><td align="center" valign="middle" rowspan="1" colspan="1">243053</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0081</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cholest-5-en-3-ol, 6-methyl-, (3.beta)-</td><td align="center" valign="middle" rowspan="1" colspan="1">29.551</td><td align="center" valign="middle" rowspan="1" colspan="1">207.00</td><td align="center" valign="middle" rowspan="1" colspan="1">243053</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0081</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">26-Hydroxycholesterol</td><td align="center" valign="middle" rowspan="1" colspan="1">29.551</td><td align="center" valign="middle" rowspan="1" colspan="1">207.00</td><td align="center" valign="middle" rowspan="1" colspan="1">243053</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0081</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Beta-Sitosterol</td><td align="center" valign="middle" rowspan="1" colspan="1">29.551</td><td align="center" valign="middle" rowspan="1" colspan="1">207.00</td><td align="center" valign="middle" rowspan="1" colspan="1">243053</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0081</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Lathosterol</td><td align="center" valign="middle" rowspan="1" colspan="1">29.551</td><td align="center" valign="middle" rowspan="1" colspan="1">207.00</td><td align="center" valign="middle" rowspan="1" colspan="1">243053</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0081</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ergost-7-en-3-ol</td><td align="center" valign="middle" rowspan="1" colspan="1">29.551</td><td align="center" valign="middle" rowspan="1" colspan="1">207.00</td><td align="center" valign="middle" rowspan="1" colspan="1">243053</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0081</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cholest-5-en-3-ol (3.beta)-, carbonochloridate</td><td align="center" valign="middle" rowspan="1" colspan="1">29.551</td><td align="center" valign="middle" rowspan="1" colspan="1">207.00</td><td align="center" valign="middle" rowspan="1" colspan="1">243053</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0081</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Stigmasterol</td><td align="center" valign="middle" rowspan="1" colspan="1">29.551</td><td align="center" valign="middle" rowspan="1" colspan="1">207.00</td><td align="center" valign="middle" rowspan="1" colspan="1">243053</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0081</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cholesta-5,22-dien-3-ol, (3.beta)-</td><td align="center" valign="middle" rowspan="1" colspan="1">29.551</td><td align="center" valign="middle" rowspan="1" colspan="1">207.00</td><td align="center" valign="middle" rowspan="1" colspan="1">243053</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0081</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ergosta-5,24(28)-dien-3-ol, (3.beta)-</td><td align="center" valign="middle" rowspan="1" colspan="1">29.551</td><td align="center" valign="middle" rowspan="1" colspan="1">207.00</td><td align="center" valign="middle" rowspan="1" colspan="1">243053</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0081</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Lathosterol</td><td align="center" valign="middle" rowspan="1" colspan="1">29.551</td><td align="center" valign="middle" rowspan="1" colspan="1">207.00</td><td align="center" valign="middle" rowspan="1" colspan="1">243053</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0081</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cholestane-3,5-diol, 5-acetate, (3.beta,5.alpha</td><td align="center" valign="middle" rowspan="1" colspan="1">29.551</td><td align="center" valign="middle" rowspan="1" colspan="1">207.00</td><td align="center" valign="middle" rowspan="1" colspan="1">243053</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0081</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">26,27-Dinorergosta-5,23-dien-3-ol, (3.beta)-</td><td align="center" valign="middle" rowspan="1" colspan="1">30.145</td><td align="center" valign="middle" rowspan="1" colspan="1">55.00</td><td align="center" valign="middle" rowspan="1" colspan="1">2543634</td><td align="center" valign="middle" rowspan="1" colspan="1">0.084769</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Desmosterol</td><td align="center" valign="middle" rowspan="1" colspan="1">30.145</td><td align="center" valign="middle" rowspan="1" colspan="1">55.00</td><td align="center" valign="middle" rowspan="1" colspan="1">2543634</td><td align="center" valign="middle" rowspan="1" colspan="1">0.084769</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5,6-Dihydroergosterol</td><td align="center" valign="middle" rowspan="1" colspan="1">30.145</td><td align="center" valign="middle" rowspan="1" colspan="1">55.00</td><td align="center" valign="middle" rowspan="1" colspan="1">2543634</td><td align="center" valign="middle" rowspan="1" colspan="1">0.084769</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">9,19-Cyclolanost-23-ene-3,25-diol, 3-acetate</td><td align="center" valign="middle" rowspan="1" colspan="1">30.787</td><td align="center" valign="middle" rowspan="1" colspan="1">207.00</td><td align="center" valign="middle" rowspan="1" colspan="1">142424</td><td align="center" valign="middle" rowspan="1" colspan="1">0.004746</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Lupeol</td><td align="center" valign="middle" rowspan="1" colspan="1">30.787</td><td align="center" valign="middle" rowspan="1" colspan="1">207.00</td><td align="center" valign="middle" rowspan="1" colspan="1">142424</td><td align="center" valign="middle" rowspan="1" colspan="1">0.004746</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3.beta-Hydroxy-5-cholen-24-oic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">31.132</td><td align="center" valign="middle" rowspan="1" colspan="1">43.00</td><td align="center" valign="middle" rowspan="1" colspan="1">4086523</td><td align="center" valign="middle" rowspan="1" colspan="1">0.136188</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">26,27-Dinorergost-5-ene-3,24-diol, (3.beta)-</td><td align="center" valign="middle" rowspan="1" colspan="1">31.132</td><td align="center" valign="middle" rowspan="1" colspan="1">43.00</td><td align="center" valign="middle" rowspan="1" colspan="1">4086523</td><td align="center" valign="middle" rowspan="1" colspan="1">0.136188</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">9,19-Cyclolanostan-3-ol, 24-methylene-, (3.beta)</td><td align="center" valign="middle" rowspan="1" colspan="1">29.551</td><td align="center" valign="middle" rowspan="1" colspan="1">95.00</td><td align="center" valign="middle" rowspan="1" colspan="1">3611829</td><td align="center" valign="middle" rowspan="1" colspan="1">0.120368</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Lupeol, trifluoroacetate</td><td align="center" valign="middle" rowspan="1" colspan="1">31.820</td><td align="center" valign="middle" rowspan="1" colspan="1">95.00</td><td align="center" valign="middle" rowspan="1" colspan="1">3611829</td><td align="center" valign="middle" rowspan="1" colspan="1">0.120368</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Lup-20(29)-en-3-ol, acetate, (3beta)-</td><td align="center" valign="middle" rowspan="1" colspan="1">32.780</td><td align="center" valign="middle" rowspan="1" colspan="1">207.00</td><td align="center" valign="middle" rowspan="1" colspan="1">1038162</td><td align="center" valign="middle" rowspan="1" colspan="1">0.034598</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Phosphonoacetic Acid, 3TMS derivative</td><td align="center" valign="middle" rowspan="1" colspan="1">5.819</td><td align="center" valign="middle" rowspan="1" colspan="1">73.00</td><td align="center" valign="middle" rowspan="1" colspan="1">653645</td><td align="center" valign="middle" rowspan="1" colspan="1">0.021783</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Nordazepam, TMS derivative</td><td align="center" valign="middle" rowspan="1" colspan="1">5.819</td><td align="center" valign="middle" rowspan="1" colspan="1">73.00</td><td align="center" valign="middle" rowspan="1" colspan="1">653645</td><td align="center" valign="middle" rowspan="1" colspan="1">0.021783</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2,6-Dihydroxybenzoic acid, 3TMS derivative</td><td align="center" valign="middle" rowspan="1" colspan="1">10.083</td><td align="center" valign="middle" rowspan="1" colspan="1">73.00</td><td align="center" valign="middle" rowspan="1" colspan="1">3196250</td><td align="center" valign="middle" rowspan="1" colspan="1">0.106518</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">aR-Turmerone</td><td align="center" valign="middle" rowspan="1" colspan="1">10.592</td><td align="center" valign="middle" rowspan="1" colspan="1">83.00</td><td align="center" valign="middle" rowspan="1" colspan="1">2528243</td><td align="center" valign="middle" rowspan="1" colspan="1">0.084256</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(Z)-.gamma.-Atlantone</td><td align="center" valign="middle" rowspan="1" colspan="1">10.592</td><td align="center" valign="middle" rowspan="1" colspan="1">83.00</td><td align="center" valign="middle" rowspan="1" colspan="1">2528243</td><td align="center" valign="middle" rowspan="1" colspan="1">0.084256</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Verbenylangelate, cis-</td><td align="center" valign="middle" rowspan="1" colspan="1">10.592</td><td align="center" valign="middle" rowspan="1" colspan="1">83.00</td><td align="center" valign="middle" rowspan="1" colspan="1">2528243</td><td align="center" valign="middle" rowspan="1" colspan="1">0.084256</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Tumerone</td><td align="center" valign="middle" rowspan="1" colspan="1">10.592</td><td align="center" valign="middle" rowspan="1" colspan="1">83.00</td><td align="center" valign="middle" rowspan="1" colspan="1">2548801</td><td align="center" valign="middle" rowspan="1" colspan="1">0.084941</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Dibutyl phthalate</td><td align="center" valign="middle" rowspan="1" colspan="1">13.793</td><td align="center" valign="middle" rowspan="1" colspan="1">149.00</td><td align="center" valign="middle" rowspan="1" colspan="1">1573158</td><td align="center" valign="middle" rowspan="1" colspan="1">0.052427</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(&#x02212;)-Globulol</td><td align="center" valign="middle" rowspan="1" colspan="1">22.159</td><td align="center" valign="middle" rowspan="1" colspan="1">79.00</td><td align="center" valign="middle" rowspan="1" colspan="1">334706</td><td align="center" valign="middle" rowspan="1" colspan="1">0.011154</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Androstan-17-one, 3-ethyl-3-hydroxy-, (5.alpha)</td><td align="center" valign="middle" rowspan="1" colspan="1">22.159</td><td align="center" valign="middle" rowspan="1" colspan="1">79.00</td><td align="center" valign="middle" rowspan="1" colspan="1">334706</td><td align="center" valign="middle" rowspan="1" colspan="1">0.011154</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Eudesma-4(15),7-dien-1.beta &#x02013;ol</td><td align="center" valign="middle" rowspan="1" colspan="1">22.159</td><td align="center" valign="middle" rowspan="1" colspan="1">79.00</td><td align="center" valign="middle" rowspan="1" colspan="1">334706</td><td align="center" valign="middle" rowspan="1" colspan="1">0.011154</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5.alpha-Cholest-8-en-3-one, 14-methyl-</td><td align="center" valign="middle" rowspan="1" colspan="1">25.771</td><td align="center" valign="middle" rowspan="1" colspan="1">95.00</td><td align="center" valign="middle" rowspan="1" colspan="1">5058177</td><td align="center" valign="middle" rowspan="1" colspan="1">0.168569</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">25-Hydroxycholesterol, 3-methyl ether</td><td align="center" valign="middle" rowspan="1" colspan="1">26.622</td><td align="center" valign="middle" rowspan="1" colspan="1">207.00</td><td align="center" valign="middle" rowspan="1" colspan="1">362457</td><td align="center" valign="middle" rowspan="1" colspan="1">0.012079</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">26-Homo-25-hydroxycholesterol</td><td align="center" valign="middle" rowspan="1" colspan="1">29.551</td><td align="center" valign="middle" rowspan="1" colspan="1">207.00</td><td align="center" valign="middle" rowspan="1" colspan="1">243053</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0081</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Betulin</td><td align="center" valign="middle" rowspan="1" colspan="1">32.780</td><td align="center" valign="middle" rowspan="1" colspan="1">207.00</td><td align="center" valign="middle" rowspan="1" colspan="1">1038162</td><td align="center" valign="middle" rowspan="1" colspan="1">0.034598</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yangambin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34.225</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">207.00</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1108879</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.036955</td></tr></tbody></table><table-wrap-foot><fn><p><italic>m</italic>/<italic>z</italic>: m stands for mass and <italic>z</italic> stands for the charge number of ions, PA: Peak Area.</p></fn></table-wrap-foot></table-wrap><table-wrap id="molecules-25-03936-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-03936-t002_Table 2</object-id><label>Table 2</label><caption><p>ADME properties of selected compounds methanol extract of <italic>T. crispa</italic> by SwissADME.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound Name</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Molecular Weight</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Num. H-Bond Acceptors</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Num. H-Bond Donors</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Log <italic>P</italic></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Molar Refractivity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">No. of Violation</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Benzeneethanamine</td><td align="center" valign="middle" rowspan="1" colspan="1">121.18</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1.7</td><td align="center" valign="middle" rowspan="1" colspan="1">38.92</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Camphenol</td><td align="center" valign="middle" rowspan="1" colspan="1">152.23</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">2.30</td><td align="center" valign="middle" rowspan="1" colspan="1">46.38</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Strophanthidin</td><td align="center" valign="middle" rowspan="1" colspan="1">404.5</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">1.82</td><td align="center" valign="middle" rowspan="1" colspan="1">106.16</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Retinal</td><td align="center" valign="middle" rowspan="1" colspan="1">284.44</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">4.39</td><td align="center" valign="middle" rowspan="1" colspan="1">93.71</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Trans-Geranylgeraniol</td><td align="center" valign="middle" rowspan="1" colspan="1">290.48</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">4.95</td><td align="center" valign="middle" rowspan="1" colspan="1">97.52</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3,4-Dihydroxymandelic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">184.15</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.36</td><td align="center" valign="middle" rowspan="1" colspan="1">43.19</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Imidazolidin-4-one, 2-imino-1-(4-methoxy-6-dimethylamino-1,3,5-triazin-2-yl)</td><td align="center" valign="middle" rowspan="1" colspan="1">251.25</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.59</td><td align="center" valign="middle" rowspan="1" colspan="1">70.28</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cholest-22-ene-21-ol, 3,5-dehydro-6-methoxy</td><td align="center" valign="middle" rowspan="1" colspan="1">498.78</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">6.39</td><td align="center" valign="middle" rowspan="1" colspan="1">151.03</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">d-Mannitol, 1-<italic>O</italic>-(16-hydroxyhexadecyl)-</td><td align="center" valign="middle" rowspan="1" colspan="1">422.60</td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">0.74</td><td align="center" valign="middle" rowspan="1" colspan="1">115.92</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Heneicosanoic acid, methyl ester</td><td align="center" valign="middle" rowspan="1" colspan="1">340.58</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">5.58</td><td align="center" valign="middle" rowspan="1" colspan="1">109.15</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Gorgost-5-en-3-ol, (3.beta)-, TMS derivative</td><td align="center" valign="middle" rowspan="1" colspan="1">498.90</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">7.49</td><td align="center" valign="middle" rowspan="1" colspan="1">157.87</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Retinol</td><td align="center" valign="middle" rowspan="1" colspan="1">286.45</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">4.48</td><td align="center" valign="middle" rowspan="1" colspan="1">94.67</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Octacosanol</td><td align="center" valign="middle" rowspan="1" colspan="1">410.76</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">7.07</td><td align="center" valign="middle" rowspan="1" colspan="1">137.87</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Alpha-Santalol</td><td align="center" valign="middle" rowspan="1" colspan="1">220.35</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">3.67</td><td align="center" valign="middle" rowspan="1" colspan="1">68.04</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Santalol, E-cis,epi-.beta-</td><td align="center" valign="middle" rowspan="1" colspan="1">220.35</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">3.56</td><td align="center" valign="middle" rowspan="1" colspan="1">69.94</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Spiro[4,5]dec-6-en-1-ol, 2,6,10,10-tetramethyl</td><td align="center" valign="middle" rowspan="1" colspan="1">208.34</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">3.41</td><td align="center" valign="middle" rowspan="1" colspan="1">65.35</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Campesterol</td><td align="center" valign="middle" rowspan="1" colspan="1">400.68</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">6.54</td><td align="center" valign="middle" rowspan="1" colspan="1">128.42</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cholesterol</td><td align="center" valign="middle" rowspan="1" colspan="1">386.65</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">6.34</td><td align="center" valign="middle" rowspan="1" colspan="1">123.61</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">9,19-Cyclocholestan-3-ol, 14-methyl-, (3.beta)</td><td align="center" valign="middle" rowspan="1" colspan="1">400.68</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">6.68</td><td align="center" valign="middle" rowspan="1" colspan="1">126.26</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cholest-5-en-3-ol, 6-methyl-, (3.beta)-</td><td align="center" valign="middle" rowspan="1" colspan="1">400.68</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">6.54</td><td align="center" valign="middle" rowspan="1" colspan="1">128.42</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">26-Hydroxycholesterol</td><td align="center" valign="middle" rowspan="1" colspan="1">402.65</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">5.41</td><td align="center" valign="middle" rowspan="1" colspan="1">124.78</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Beta-Sitosterol</td><td align="center" valign="middle" rowspan="1" colspan="1">414.71</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">6.73</td><td align="center" valign="middle" rowspan="1" colspan="1">133.23</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Lathosterol</td><td align="center" valign="middle" rowspan="1" colspan="1">386.65</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">6.34</td><td align="center" valign="middle" rowspan="1" colspan="1">123.61</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ergost-7-en-3-ol</td><td align="center" valign="middle" rowspan="1" colspan="1">400.68</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">6.54</td><td align="center" valign="middle" rowspan="1" colspan="1">128.42</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cholest-5-en-3-ol (3.beta)-, carbonochloridate</td><td align="center" valign="middle" rowspan="1" colspan="1">449.11</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">6.51</td><td align="center" valign="middle" rowspan="1" colspan="1">133.73</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Stigmasterol</td><td align="center" valign="middle" rowspan="1" colspan="1">412.69</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">6.62</td><td align="center" valign="middle" rowspan="1" colspan="1">132.75</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cholesta-5,22-dien-3-ol, (3.beta)-</td><td align="center" valign="middle" rowspan="1" colspan="1">384.64</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">6.23</td><td align="center" valign="middle" rowspan="1" colspan="1">123.14</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ergosta-5,24(28)-dien-3-ol, (3.beta)-</td><td align="center" valign="middle" rowspan="1" colspan="1">398.66</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">6.43</td><td align="center" valign="middle" rowspan="1" colspan="1">127.95</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Lathosterol</td><td align="center" valign="middle" rowspan="1" colspan="1">386.65</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">6.34</td><td align="center" valign="middle" rowspan="1" colspan="1">123.61</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cholestane-3,5-diol, 5-acetate, (3.beta,5.alpha</td><td align="center" valign="middle" rowspan="1" colspan="1">446.71</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">5.74</td><td align="center" valign="middle" rowspan="1" colspan="1">135.03</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">26,27-Dinorergosta-5,23-dien-3-ol, (3.beta)-</td><td align="center" valign="middle" rowspan="1" colspan="1">370.61</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">6.03</td><td align="center" valign="middle" rowspan="1" colspan="1">118.33</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Desmosterol</td><td align="center" valign="middle" rowspan="1" colspan="1">384.64</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">6.23</td><td align="center" valign="middle" rowspan="1" colspan="1">123.14</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5,6-Dihydroergosterol</td><td align="center" valign="middle" rowspan="1" colspan="1">398.66</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">6.43</td><td align="center" valign="middle" rowspan="1" colspan="1">127.95</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">9,19-Cyclolanost-23-ene-3,25-diol, 3-acetate</td><td align="center" valign="middle" rowspan="1" colspan="1">484.75</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">6.20</td><td align="center" valign="middle" rowspan="1" colspan="1">146.08</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Lupeol</td><td align="center" valign="middle" rowspan="1" colspan="1">426.72</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">6.92</td><td align="center" valign="middle" rowspan="1" colspan="1">135.14</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3.beta-Hydroxy-5-cholen-24-oic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">374.56</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">4.62</td><td align="center" valign="middle" rowspan="1" colspan="1">110.97</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">26,27-Dinorergost-5-ene-3,24-diol, (3.beta)-</td><td align="center" valign="middle" rowspan="1" colspan="1">388.63</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">5.21</td><td align="center" valign="middle" rowspan="1" colspan="1">120.01</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">9,19-Cyclolanostan-3-ol, 24-methylene-, (3.beta)</td><td align="center" valign="middle" rowspan="1" colspan="1">440.74</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">7.12</td><td align="center" valign="middle" rowspan="1" colspan="1">139.95</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Lupeol, trifluoroacetate</td><td align="center" valign="middle" rowspan="1" colspan="1">522.73</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">7.36</td><td align="center" valign="middle" rowspan="1" colspan="1">145.07</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Lup-20(29)-en-3-ol, acetate, (3beta)-</td><td align="center" valign="middle" rowspan="1" colspan="1">468.75</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">7.08</td><td align="center" valign="middle" rowspan="1" colspan="1">144,.88</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Phosphonoacetic Acid, 3TMS derivative</td><td align="center" valign="middle" rowspan="1" colspan="1">356.58</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">1.42</td><td align="center" valign="middle" rowspan="1" colspan="1">90.71</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Nordazepam, TMS derivative</td><td align="center" valign="middle" rowspan="1" colspan="1">342.89</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">3.14</td><td align="center" valign="middle" rowspan="1" colspan="1">105.43</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2,6-Dihydroxybenzoic acid, 3TMS derivative</td><td align="center" valign="middle" rowspan="1" colspan="1">370.66</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">2.97</td><td align="center" valign="middle" rowspan="1" colspan="1">103.15</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">aR-Turmerone</td><td align="center" valign="middle" rowspan="1" colspan="1">216.32</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">3.68</td><td align="center" valign="middle" rowspan="1" colspan="1">69.75</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<italic>Z</italic>)-gamma.-Atlantone</td><td align="center" valign="middle" rowspan="1" colspan="1">218.33</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">3.37</td><td align="center" valign="middle" rowspan="1" colspan="1">70.88</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Verbenylangelate, cis-</td><td align="center" valign="middle" rowspan="1" colspan="1">234.33</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">3.35</td><td align="center" valign="middle" rowspan="1" colspan="1">70.07</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Tumerone</td><td align="center" valign="middle" rowspan="1" colspan="1">218.33</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">3.37</td><td align="center" valign="middle" rowspan="1" colspan="1">70.88</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Dibutyl phthalate</td><td align="center" valign="middle" rowspan="1" colspan="1">278.34</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">3.43</td><td align="center" valign="middle" rowspan="1" colspan="1">77.84</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(&#x02212;)-Globulol</td><td align="center" valign="middle" rowspan="1" colspan="1">222.37</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">3.81</td><td align="center" valign="middle" rowspan="1" colspan="1">68.82</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Androstan-17-one, 3-ethyl-3-hydroxy-,(5.alpha)</td><td align="center" valign="middle" rowspan="1" colspan="1">318.49</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">4.15</td><td align="center" valign="middle" rowspan="1" colspan="1">95.48</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Eudesma-4(15),7-dien-1.beta&#x02013;ol</td><td align="center" valign="middle" rowspan="1" colspan="1">220.35</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">3.56</td><td align="center" valign="middle" rowspan="1" colspan="1">69.94</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.alpha-Cholest-8-en-3-one, 14-methyl-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">398.66</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.43</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">127.20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr></tbody></table></table-wrap><table-wrap id="molecules-25-03936-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-03936-t003_Table 3</object-id><label>Table 3</label><caption><p>Molecular docking study of major bioactive compounds of methanol extract of <italic>T. crispa.</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound Name</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Docking Score</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Residues Interacting with<break/>Ligand through H-Bonding (H-Bonds No.)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Hydrophobic Bonds (pi-Alkyl Stacked)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Hydrophobic Bonds (pi-pi Stacked)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Camphenol</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.177</td><td align="center" valign="middle" rowspan="1" colspan="1">His164</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">His41, Met49 (3), Met165</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Strophanthidin</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.8</td><td align="center" valign="middle" rowspan="1" colspan="1">Gln189</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Met165</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Benzeneethanamine</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.022</td><td align="center" valign="middle" rowspan="1" colspan="1">His41</td><td align="center" valign="middle" rowspan="1" colspan="1">His41</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Retinal</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.591</td><td align="center" valign="middle" rowspan="1" colspan="1">His163</td><td align="center" valign="middle" rowspan="1" colspan="1">His41, Cys145,Cys44, Met49</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Trans-geranylgeraniol</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;3.393</td><td align="center" valign="middle" rowspan="1" colspan="1">His163, Ser144</td><td align="center" valign="middle" rowspan="1" colspan="1">Met49 (2), Arg188</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3,4-Dihydroxymandelic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.51</td><td align="center" valign="middle" rowspan="1" colspan="1">Gly143,Ser144</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Imidazolidin-4-one, 2-imino-1-(4-methoxy-6-dimethylamino-1,3,5-triazin-2-yl)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.013</td><td align="center" valign="middle" rowspan="1" colspan="1">Glu166 (2), Gln192</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Retinol</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.576</td><td align="center" valign="middle" rowspan="1" colspan="1">Thr24</td><td align="center" valign="middle" rowspan="1" colspan="1">Cys145, Met165, His41, Cys44, Met49</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Alpha-Santalol</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.595</td><td align="center" valign="middle" rowspan="1" colspan="1">Gln192</td><td align="center" valign="middle" rowspan="1" colspan="1">His41 (2), Met49 (3), Pro168, Met165</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Santalol, E-cis, epi-beta-</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.664</td><td align="center" valign="middle" rowspan="1" colspan="1">Gln192</td><td align="center" valign="middle" rowspan="1" colspan="1">His41, Met49 (2), Pro168,</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Spiro[4,5]dec-6-en-1-ol, 2,6,10,10-tetramethyl</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.369</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Met165 (3), His41 (4), Met49 (2), Cys145</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3.beta-Hydroxy-5-cholen-24-oic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.251</td><td align="center" valign="middle" rowspan="1" colspan="1">Thr25, Thr190,Gln192</td><td align="center" valign="middle" rowspan="1" colspan="1">Met49 (3), His41, Met165 (2)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Phosphonoacetic Acid, 3TMS derivative</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.273</td><td align="center" valign="middle" rowspan="1" colspan="1">Glu166</td><td align="center" valign="middle" rowspan="1" colspan="1">Cys145 (2), His41 (2), Met165, His163</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Nordazepam, TMS derivative</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.122</td><td align="center" valign="middle" rowspan="1" colspan="1">Glu166</td><td align="center" valign="middle" rowspan="1" colspan="1">Met165</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2,6-Dihydroxybenzoic acid, 3TMS derivative</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;4.696</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Met165 (2), His41 (3), Cys145</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">aR-Turmerone</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.452</td><td align="center" valign="middle" rowspan="1" colspan="1">Cys44</td><td align="center" valign="middle" rowspan="1" colspan="1">Met165, Pro168, His41 (2), Met49</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(Z)-gamma.-Atlantone</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.708</td><td align="center" valign="middle" rowspan="1" colspan="1">Gln189</td><td align="center" valign="middle" rowspan="1" colspan="1">Met49, Met165, His41, Pro168 (2)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Verbenyl angelate, cis-</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.579</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Met165 (2), Pro52, Arg188, Cys44 (4), Met49 (4)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Tumerone</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;5.131</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Met165 (2), His41 (2), Cys44</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Dibutyl phthalate</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.279</td><td align="center" valign="middle" rowspan="1" colspan="1">Gly143, Asn142</td><td align="center" valign="middle" rowspan="1" colspan="1">His41, His163, His172</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(&#x02212;)-Globulol</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.165</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Met49 (2), His41(4), Cys44 (2), Met165 (3)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Androstan-17-one, 3-ethyl-3-hydroxy-(5.alpha)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.218</td><td align="center" valign="middle" rowspan="1" colspan="1">Thr26</td><td align="center" valign="middle" rowspan="1" colspan="1">Cys145, Met49, His41 (3)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Yangambin</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;6.162</td><td align="center" valign="middle" rowspan="1" colspan="1">Thr25</td><td align="center" valign="middle" rowspan="1" colspan="1">Met49, Met165</td><td align="center" valign="middle" rowspan="1" colspan="1">His41</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Nelfinavir</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;7.596</td><td align="center" valign="middle" rowspan="1" colspan="1">His41,<break/>Glu166 (2)</td><td align="center" valign="middle" rowspan="1" colspan="1">His41</td><td align="center" valign="middle" rowspan="1" colspan="1">Met165</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lopinavir</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;8.251</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gln189, Glu166, Cys141, Thr26</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pro168,<break/>His41 (2)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Arg188, His41</td></tr></tbody></table></table-wrap><table-wrap id="molecules-25-03936-t004" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-03936-t004_Table 4</object-id><label>Table 4</label><caption><p>Biological activity prediction of methanol extract of <italic>T. crispa.</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compounds</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">GPCR Ligand</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ion Channel Inhibitor</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Kinase Inhibitor</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Nuclear Receptor Ligand</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Protease Inhibitor</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Enzyme Inhibitor</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Benzeneethanamine</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.71</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.16</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.95</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;2.61</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.85</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.43</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Camphenol</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.66</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.43</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.53</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.62</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.06</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.37</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Strophanthidin</td><td align="center" valign="middle" rowspan="1" colspan="1">0.08</td><td align="center" valign="middle" rowspan="1" colspan="1">0.07</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.46</td><td align="center" valign="middle" rowspan="1" colspan="1">0.52</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">0.79</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Retinal</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.15</td><td align="center" valign="middle" rowspan="1" colspan="1">0.15</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.23</td><td align="center" valign="middle" rowspan="1" colspan="1">0.90</td><td align="center" valign="middle" rowspan="1" colspan="1">0.09</td><td align="center" valign="middle" rowspan="1" colspan="1">0.52</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Trans-Geranylgeraniol</td><td align="center" valign="middle" rowspan="1" colspan="1">0.12</td><td align="center" valign="middle" rowspan="1" colspan="1">0.20</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.22</td><td align="center" valign="middle" rowspan="1" colspan="1">0.40</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.08</td><td align="center" valign="middle" rowspan="1" colspan="1">0.41</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3,4-Dihydroxymandelic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.28</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.18</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.69</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.06</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.61</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.05</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Imidazolidin-4-one, 2-imino-1-(4-methoxy-6-dimethylamino-1,3,5-triazin-2-yl)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.15</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.15</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.20</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.63</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.55</td><td align="center" valign="middle" rowspan="1" colspan="1">0.08</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Retinol</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">0.32</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.25</td><td align="center" valign="middle" rowspan="1" colspan="1">1.02</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.16</td><td align="center" valign="middle" rowspan="1" colspan="1">0.66</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Alpha-Santalol</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.04</td><td align="center" valign="middle" rowspan="1" colspan="1">0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.43</td><td align="center" valign="middle" rowspan="1" colspan="1">0.12</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.22</td><td align="center" valign="middle" rowspan="1" colspan="1">0.37</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Santalol, <italic>E</italic>-cis,epi-.beta-</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.09</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.04</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.65</td><td align="center" valign="middle" rowspan="1" colspan="1">0.23</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.42</td><td align="center" valign="middle" rowspan="1" colspan="1">0.39</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Spiro[4,5]dec-6-en-1-ol, 2,6,10,10-tetramethyl</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.23</td><td align="center" valign="middle" rowspan="1" colspan="1">0.00</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.79</td><td align="center" valign="middle" rowspan="1" colspan="1">0.40</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.27</td><td align="center" valign="middle" rowspan="1" colspan="1">0.43</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3.beta-Hydroxy-5-cholen-24-oic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">0.20</td><td align="center" valign="middle" rowspan="1" colspan="1">0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.57</td><td align="center" valign="middle" rowspan="1" colspan="1">0.87</td><td align="center" valign="middle" rowspan="1" colspan="1">0.07</td><td align="center" valign="middle" rowspan="1" colspan="1">0.64</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Phosphonoacetic Acid, 3TMS derivative</td><td align="center" valign="middle" rowspan="1" colspan="1">0.43</td><td align="center" valign="middle" rowspan="1" colspan="1">0.59</td><td align="center" valign="middle" rowspan="1" colspan="1">0.12</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.05</td><td align="center" valign="middle" rowspan="1" colspan="1">0.71</td><td align="center" valign="middle" rowspan="1" colspan="1">1.08</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Nordazepam, TMS derivative</td><td align="center" valign="middle" rowspan="1" colspan="1">0.48</td><td align="center" valign="middle" rowspan="1" colspan="1">0.58</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.22</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.07</td><td align="center" valign="middle" rowspan="1" colspan="1">0.33</td><td align="center" valign="middle" rowspan="1" colspan="1">0.35</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2,6-Dihydroxybenzoic acid, 3TMS derivative</td><td align="center" valign="middle" rowspan="1" colspan="1">0.34</td><td align="center" valign="middle" rowspan="1" colspan="1">0.12</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.06</td><td align="center" valign="middle" rowspan="1" colspan="1">0.42</td><td align="center" valign="middle" rowspan="1" colspan="1">0.72</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">aR-Turmerone</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.68</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.46</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.36</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.14</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.80</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.25</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<italic>Z</italic>)-gamma.-Atlantone</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.38</td><td align="center" valign="middle" rowspan="1" colspan="1">0.15</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.17</td><td align="center" valign="middle" rowspan="1" colspan="1">0.37</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.58</td><td align="center" valign="middle" rowspan="1" colspan="1">0.46</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Verbenyl angelate, cis-</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.09</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.08</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.98</td><td align="center" valign="middle" rowspan="1" colspan="1">0.32</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.35</td><td align="center" valign="middle" rowspan="1" colspan="1">0.28</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Tumerone</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.35</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.13</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.19</td><td align="center" valign="middle" rowspan="1" colspan="1">0.54</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.44</td><td align="center" valign="middle" rowspan="1" colspan="1">0.41</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Dibutyl phthalate</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.16</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.09</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.27</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.12</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.25</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.07</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(&#x02212;)-Globulol</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.50</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.29</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.82</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.22</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.48</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.13</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Androstan-17-one, 3-ethyl-3-hydroxy-, (5.alpha)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.19</td><td align="center" valign="middle" rowspan="1" colspan="1">0.41</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.35</td><td align="center" valign="middle" rowspan="1" colspan="1">0.83</td><td align="center" valign="middle" rowspan="1" colspan="1">0.17</td><td align="center" valign="middle" rowspan="1" colspan="1">0.66</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Yangambin</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.25</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.19</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.10</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.16</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Nelfinavir</td><td align="center" valign="middle" rowspan="1" colspan="1">0.19</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.25</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.28</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.25</td><td align="center" valign="middle" rowspan="1" colspan="1">0.58</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.02</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lopinavir</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.04</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.78</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.55</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.66</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.42</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.37</td></tr></tbody></table></table-wrap></floats-group></article>